Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3032700	s-gbmab	— (—)	4120	5120	100.00%	Distribution not available
3032700	s-goodpk	— (—)	493	569	100.00%	Distribution not available
3032700	s-gbmab	U/ml (u/ml)	40	138	23.19%
3032700	s-goodpk	U/ml (u/ml)	28	175	0.00%
3032700	glomerulustyvikalvo,vasta-aineet	— (—)	23	29	100.00%	Distribution not available
3032700	s-gbm-ab	— (—)	6	7	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Implicit bacterial Sepsis

1046

1423

6.55

307.65

1.3

1.2

48.62

12.26

u/ml

—

Systemic connective tissue disorders

745

1429

5.39

307.65

2.4

1.1

73.21

13.92

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1504

2264

4.57

307.65

1.4

1.3

47.26

50.74

u/ml

0.03

Bacterial infection, other or unspecified, including avohilmo

1126

1963

4.82

307.65

1.4

1.2

46.62

41.71

u/ml

0.04

Bacterial infection, other or unspecified

1061

1868

4.92

307.65

1.4

1.2

50.11

49.20

u/ml

—

Heart failure,strict

920

1361

4.84

307.65

1.2

26.22

59.90

u/ml

—

First line medication for Crohn's disease

1457

2268

3.50

307.65

1.5

1.1

22.01

42.59

u/ml

0.25

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1548

2669

3.93

307.65

1.4

1.3

62.43

29.67

u/ml

0.37

Oral corticosteroids

1602

2553

3.74

307.65

1.5

1.1

43.77

41.76

u/ml

0.02

Fever of other and unknown origin

988

1865

4.69

307.65

1.4

1.2

67.99

5.81

u/ml

0.84

Influenza and pneumonia

1574

2566

3.85

307.65

1.4

1.3

54.29

32.37

u/ml

0.25

Other bacterial diseases

1525

2595

3.97

307.65

1.4

1.3

54.86

62.87

u/ml

0.07

Renal tubulo-interstitial diseases

2135

1978

8.19

307.65

1.4

1.2

38.69

46.16

u/ml

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1388

1922

4.30

307.65

1.4

1.2

67.87

42.87

u/ml

0.21

Other bacterial diseases, including avohilmo

1506

2542

3.76

307.65

1.4

1.3

58.27

51.37

u/ml

0.06

All pneumoniae

1570

2632

3.94

307.65

1.4

1.3

58.04

30.98

u/ml

0.31

All kidney diseases

2172

1892

7.92

307.65

1.4

1.2

51.07

21.27

u/ml

—

Pneumonia, organism unspecified

1441

2464

4.08

307.65

1.3

84.40

33.94

u/ml

0.57

Implicit Sepsis, including avohilmo

1546

2271

4.98

307.65

1.4

1.3

39.27

60.74

u/ml

—

Other necrotizing vasculopathies (FG)

300

219

15.40

307.65

3.0

1.1

11.30

—

u/ml

—

Implicit bacterial Sepsis, including avohilmo

1118

1517

6.36

307.65

1.3

1.2

48.62

12.26

u/ml

—

ILD medications: prednisolone, methylprednisolone, prednisone

1591

2257

3.98

307.65

1.6

1.1

40.96

9.88

u/ml

—

Other respiratory diseases principally affecting the interstitium

616

800

8.23

307.65

1.2

1.1

9.12

20.60

u/ml

—

1388

1922

4.30

307.65

1.4

1.2

67.87

42.87

u/ml

0.21

Inflammatory bowel disease treatment related agents

1587

2601

3.43

307.65

1.5

1.1

44.20

40.46

u/ml

0.04

Other necrotizing vasculopathies

364

300

13.69

307.65

3.7

1.1

84.19

—

u/ml

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1647

2713

4.17

307.65

1.3

12.86

69.30

u/ml

1.25

ILD medications

1603

2272

3.86

307.65

1.6

1.1

39.17

9.88

u/ml

—

ILD medications: immunosuppressive drugs

1104

2053

4.98

307.65

1.9

1.1

59.95

11.99

u/ml

—

Implicit Sepsis

1516

2192

5.23

307.65

1.4

1.2

54.30

62.40

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

1566

2631

3.96

307.65

1.4

1.3

58.04

32.08

u/ml

0.29

Condition for Implicit Sepsis (Organ dysfunction codes)

1543

2248

4.86

307.65

1.4

1.3

41.14

55.26

u/ml

0.13

Bacterial Sepsis

1108

1553

6.11

307.65

1.3

1.2

48.62

12.26

u/ml

—

Heart failure, not strict

1386

1869

5.12

307.65

1.3

24.54

76.75

u/ml

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1102

2795

3.50

299.60

1.4

1.2

39.35

46.02

u/ml

—

Explicit Sepsis

754

1556

4.52

294.69

1.2

76.39

10.38

u/ml

—

Explicit Sepsis, including avohilmo

766

1596

4.45

293.57

1.2

76.39

10.38

u/ml

—

Abnormal findings on diagnostic imaging of lung

882

2196

3.90

286.69

1.4

1.2

34.82

33.25

u/ml

—

Septicaemia

739

1569

4.40

279.24

1.2

76.39

13.55

u/ml

—

Heart failure, strict

989

1905

3.69

270.58

1.2

26.22

40.74

u/ml

—

Hypertensive diseases (excluding secondary)

638

663

5.69

269.12

1.3

1.4

18.27

70.05

u/ml

—

Acute tubulo-interstitial nephritis

773

1596

4.15

266.42

1.3

1.2

70.63

68.17

u/ml

—

All-cause Heart Failure

974

1884

3.68

265.30

1.2

26.22

40.63

u/ml

—

Other septicaemia

667

1447

4.45

258.84

1.2

1.3

120.40

13.55

u/ml

—

Other septicaemia, including avohilmo

675

1473

4.41

258.05

1.2

120.40

13.55

u/ml

—

Autoimmune diseases related-to ILD

1107

3067

3.05

240.63

2.0

1.1

72.99

18.03

u/ml

0.99

Autoimmune diseases excluding thyroid diseases

1341

2524

2.91

236.34

1.7

1.1

46.41

16.88

u/ml

0.48

Asthma, unspecified (mode), excluding more controls

603

906

4.83

235.82

1.2

1.1

34.16

15.29

u/ml

—

Bacterial pneumoniae

653

1379

4.25

233.75

1.5

1.3

90.70

19.54

u/ml

—

Bacterial pneumonia, not elsewhere classified

632

1306

4.34

232.79

1.5

1.3

90.70

19.54

u/ml

—

Hypertensive diseases

918

1456

3.60

227.27

1.3

36.66

37.20

u/ml

—

Hypertension

917

1456

3.60

226.61

1.3

36.66

37.20

u/ml

—

Autoimmune diseases excluding thyroid diseases, strict definition

1294

2464

2.89

225.25

1.7

1.1

46.41

17.69

u/ml

0.46

Asthma, excluding more controls

770

960

4.17

221.26

1.2

1.1

75.44

15.29

u/ml

—

Asthma (only as main-diagnosis), excluding more controls

722

960

4.21

216.80

1.3

1.1

60.25

15.29

u/ml

—

Asthma, unspecified (mode)

618

1068

4.23

207.46

1.2

1.1

34.16

19.56

u/ml

—

Hypertension, essential

867

1425

3.48

204.94

1.3

41.11

37.20

u/ml

—

Cardiovascular diseases (excluding rheumatic etc)

637

843

4.37

203.23

1.2

1.5

15.73

55.59

u/ml

—

Bacterial pneumonia (organism specified)

724

1895

3.53

201.94

1.5

1.3

79.60

16.72

u/ml

—

Erysipelas, including avohilmo

924

2235

3.10

199.90

1.3

1.2

7.54

65.74

u/ml

—

Dyspnoea

1158

3116

2.72

196.18

1.3

124.36

12.03

u/ml

—

Asthma (only as main-diagnosis)

744

1131

3.72

192.10

1.3

1.1

57.23

19.56

u/ml

—

Asthma

789

1131

3.64

191.49

1.2

1.1

75.44

19.56

u/ml

—

Asthma (mode)

781

1147

3.62

189.45

1.3

1.1

68.14

19.56

u/ml

—

General symptoms and signs

1169

2114

2.80

187.39

1.3

1.2

25.27

4.87

u/ml

—

Metabolic disorders

1123

2494

2.73

182.71

1.2

1.3

35.03

50.58

u/ml

—

Abnormalities of breathing

1021

2042

2.89

181.19

1.3

107.00

14.61

u/ml

—

Erysipelas

736

2013

3.20

174.43

1.2

3.92

53.82

u/ml

—

Persons encountering health services for specific procedures and health care

1228

2885

2.54

172.68

1.4

1.2

59.30

31.28

u/ml

0.29

Transplanted organ and tissue status

251

356

7.43

168.78

2.2

1.1

56.58

—

u/ml

—

Type 2 diabetes, wide definition

980

2240

2.79

168.55

1.2

1.3

109.86

57.72

u/ml

—

Other disorders of fluid, electrolyte and acid-base balance

504

1226

3.96

167.78

1.3

13.42

11.57

u/ml

—

COPD/asthma related infections

1054

1922

2.77

166.51

1.3

1.2

12.41

42.87

u/ml

—

COPD/asthma/ILD related infections

1054

1922

2.77

166.51

1.3

1.2

12.41

42.87

u/ml

—

Insulin medication

819

2372

2.91

163.03

1.2

1.3

108.60

38.39

u/ml

—

Cardiovascular diseases

556

731

4.08

158.40

1.2

1.5

18.18

58.53

u/ml

—

Other heart diseases, wide

982

2215

2.71

158.17

1.3

25.47

70.50

u/ml

—

Gout

497

1124

3.89

156.77

1.2

21.36

16.19

u/ml

—

Second line medication for Crohn's disease

753

2659

2.87

153.20

1.9

1.2

61.61

57.12

u/ml

—

Reimbursement for rheumatic diseases

736

2569

2.89

151.36

2.0

1.2

87.09

43.39

u/ml

0.38

L04AX Other immunosuppressants

736

2599

2.87

149.93

1.9

1.2

61.61

59.63

u/ml

—

Heart failure and coronary heart disease

654

1437

3.25

149.23

1.3

1.2

26.22

43.87

u/ml

—

Bleeding

1029

2905

2.51

148.69

1.3

86.04

29.47

u/ml

—

Certain infectious and parasitic diseases

974

1824

2.70

146.70

1.3

1.2

20.33

53.82

u/ml

—

Other diseases of pleura

689

2035

3.00

146.00

1.5

1.2

6.85

17.04

u/ml

—

Any gastric operation

726

1149

3.20

145.33

1.4

1.2

21.18

24.89

u/ml

—

GASTRO-related operations

726

1149

3.20

145.33

1.4

1.2

21.18

24.89

u/ml

—

Autoimmune diseases

1192

2533

2.41

144.32

1.6

1.1

15.46

16.88

u/ml

0.05

Gout, FINNGEN

497

1419

3.57

143.93

1.2

21.36

10.66

u/ml

—

Antihypertensive medication - note that there are other indications

549

759

3.82

143.11

1.4

20.85

2.56

u/ml

—

Insulin, combination of fast acting with intermediate-acting or long-acting

819

2817

2.67

142.45

1.2

1.3

108.60

19.70

u/ml

—

Diabetes mellitus

1082

2652

2.38

132.38

1.2

1.3

21.92

47.69

u/ml

—

Covid-19 confirmed case

558

1819

3.12

131.36

1.5

1.2

71.06

18.78

u/ml

—

Diabetes, varying definitions

1076

2653

2.37

131.24

1.2

1.3

21.92

47.69

u/ml

—

Type 2 diabetes

1048

2561

2.39

129.86

1.2

1.3

101.75

47.69

u/ml

—

Asthma, hospital admissions 3, pneumonia

533

1702

3.18

129.37

1.2

36.09

13.24

u/ml

—

Asthma-related pneumonia or sepsis

533

1702

3.18

129.37

1.2

36.09

13.24

u/ml

—

Asthma-related pneumonia

532

1699

3.18

129.12

1.2

36.09

13.24

u/ml

—

Malaise and fatigue

598

1601

2.98

122.98

1.4

1.2

70.89

6.18

u/ml

—

Used for control exclusion in common control thyroid runs

1084

2370

2.33

121.55

1.5

1.1

18.14

17.69

u/ml

—

COPD (mode)

355

680

4.14

119.05

1.1

—

24.13

u/ml

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

985

2522

2.34

117.15

1.2

1.3

15.08

47.69

u/ml

—

Asthma, hospital admission 2, infections

719

2774

2.56

116.48

1.2

1.3

32.27

31.31

u/ml

—

Asthma-related infections

719

2774

2.56

116.48

1.2

1.3

32.27

31.31

u/ml

—

Provisional assignment of new diseases of uncertain etiology

666

2528

2.65

116.04

1.5

1.3

71.06

13.73

u/ml

—

Codes for special purposes

666

2530

2.64

115.83

1.5

1.3

71.06

13.72

u/ml

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

717

2190

2.60

114.49

1.2

1.3

94.92

33.87

u/ml

—

Finngen Rheumatological endpoints

951

2313

2.35

113.45

1.4

1.2

19.54

78.16

u/ml

—

Valvular heart disease excluding rheumatic fever

540

1290

3.03

111.35

1.3

1.2

21.47

54.06

u/ml

—

Non-rheumatic valve diseases

535

1280

3.02

109.88

1.3

1.2

21.47

54.06

u/ml

—

Nutritional anaemias

629

2305

2.64

107.87

1.2

16.10

30.81

u/ml

—

Tramadol

838

2104

2.42

107.63

1.2

1.4

79.49

40.67

u/ml

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1018

2965

2.19

105.64

1.4

1.3

59.84

50.59

u/ml

0.08

Dental caries

375

1067

3.38

99.38

1.6

1.2

9.08

76.19

u/ml

—

Hard cardiovascular diseases

867

2250

2.30

99.24

1.2

1.4

126.47

47.94

u/ml

—

Symptoms and signs involving the circulatory and respiratory systems

922

2046

2.27

98.54

1.3

9.61

14.61

u/ml

—

Ischemic heart diseases

870

2291

2.28

98.21

1.1

1.4

55.76

71.00

u/ml

—

Diabetes, insulin treatment (Kela reimbursement)

1045

2968

2.11

97.99

1.2

1.3

15.08

57.87

u/ml

—

Diseases of arteries, arterioles and capillaries

797

2571

2.30

96.28

1.3

1.2

60.43

17.69

u/ml

—

Percutaneous Coronary Intervention

834

2239

2.29

95.18

1.1

1.3

42.37

71.00

u/ml

—

Abnormal findings on examination of blood, without diagnosis

625

2298

2.50

94.66

1.4

1.2

57.27

13.22

u/ml

—

Major coronary heart disease event

884

2402

2.22

93.94

1.1

1.3

47.77

67.85

u/ml

—

Coronary revascularization (ANGIO or CABG)

829

2239

2.27

93.03

1.1

1.3

42.37

71.00

u/ml

—

Type 2 diabetes, definitions combined

913

2476

2.16

90.35

1.2

1.3

101.75

47.69

u/ml

—

Type 2 diabetes, strict (exclude DM1)

916

2504

2.14

88.90

1.2

1.3

101.75

47.69

u/ml

—

Asthma (diagnoses ohter than nonallergic)

917

3593

2.08

88.49

1.2

1.3

33.14

51.33

u/ml

—

Type 2 diabetes, definitions combined, including avohilmo

913

2489

2.14

87.67

1.2

1.3

101.75

47.69

u/ml

—

Complications of medical and surgical care

802

3362

2.16

87.63

1.2

1.3

89.01

42.49

u/ml

—

Diabetes medication

1021

2957

2.03

86.24

1.2

1.3

94.92

43.31

u/ml

—

Other disorders of skin and subcutaneous tissue

797

3171

2.14

83.81

1.3

52.57

52.79

u/ml

—

Symptoms and signs involving the urinary system

831

2976

2.13

83.76

1.3

9.72

47.85

u/ml

—

Emergency coronary revascularization (for ACS)

884

2545

2.12

83.60

1.1

1.3

42.37

67.85

u/ml

—

Chronic lower respiratory diseases

1164

3205

1.92

82.50

1.2

1.3

68.39

42.87

u/ml

—

Endocrine, nutritional and metabolic diseases

663

1399

2.41

80.71

1.3

1.4

20.92

33.90

u/ml

—

All influenza

301

918

3.33

79.50

1.2

36.86

24.38

u/ml

—

Hypersensitivity angiitis

42.54

79.25

12.2

1.1

100.76

—

u/ml

—

486

1928

2.53

77.59

1.2

1.3

37.45

17.24

u/ml

—

Complications of surgical and medical care, not elsewhere classified

998

3452

1.94

76.89

1.3

55.83

43.89

u/ml

0.12

Cough

423

1475

2.70

76.50

1.4

1.3

7.20

18.92

u/ml

—

Pain in throat and chest

727

2014

2.15

71.68

1.3

10.06

14.61

u/ml

—

Other acute lower respiratory infections

587

2513

2.25

71.32

1.4

1.3

8.06

22.47

u/ml

—

1053

2869

1.87

68.20

1.5

1.2

8.77

68.69

u/ml

—

Major coronary heart disease event excluding revascularizations

630

1901

2.21

67.87

1.2

1.3

25.96

37.09

u/ml

—

Opioids

861

2257

1.98

66.19

1.3

1.4

8.22

39.01

u/ml

—

Asthma, hospital admissions , main diagnosis only

801

3596

1.95

66.10

1.2

1.3

57.23

43.81

u/ml

0.14

Isolated proteinuria with specified morphological lesion

17.26

65.12

1.0

1.1

—

u/ml

—

Other (not insulin) diabetes medications

898

2805

1.89

62.29

1.2

1.3

113.70

43.31

u/ml

—

Peripheral artery disease

518

1824

2.27

62.07

1.2

6.96

21.62

u/ml

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

624

3013

2.05

60.31

1.3

89.01

48.17

u/ml

—

Intestinal infectious diseases

899

3673

1.83

59.42

1.3

62.58

41.03

u/ml

—

Asthma/COPD (KELA code 203)

877

3201

1.84

57.84

1.2

1.3

68.70

42.87

u/ml

—

Diarrhoea and gastroenteritis of presumed infectious origin

682

3125

1.96

57.61

1.4

1.3

66.03

34.49

u/ml

—

Complications of procedures, not elsewhere classified

779

3368

1.88

56.45

1.2

1.3

66.74

43.89

u/ml

0.19

Parasetamol

601

1427

2.14

56.38

1.3

1.4

13.78

51.63

u/ml

—

Atherosclerosis, excluding cerebral and coronary sclerosis

482

1709

2.24

56.07

1.2

7.85

21.62

u/ml

—

Coronary atherosclerosis

613

1901

2.05

54.41

1.1

1.3

25.63

66.97

u/ml

—

Rheumatoid arthritis

327

1150

2.55

51.96

1.1

1.3

—

76.63

u/ml

—

Statin medication

538

1425

2.14

51.90

1.1

1.3

11.64

59.70

u/ml

—

Giant cell arteritis

159

6.07

51.36

1.2

1.0

—

Seropositive rheumatoid arthritis

250

883

2.85

50.87

1.1

—

82.10

u/ml

—

Polyarteritis nodosa and related conditions

10.87

50.67

1.6

1.1

—

Codeine or tramadol medication

999

3171

1.72

50.21

1.2

1.3

8.34

53.67

u/ml

—

Bronchitis

987

3492

1.70

49.08

1.6

1.2

7.36

56.81

u/ml

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

17.65

48.49

1.1

—

Acute nephritic syndrome

9.31

48.44

1.6

1.1

—

Nausea and vomiting

295

1167

2.49

45.86

1.5

1.2

88.60

16.62

u/ml

—

Sleep apnoea

860

3172

1.72

44.62

1.2

1.3

40.62

57.34

u/ml

—

Diseases of the skin and subcutaneous tissue

834

2404

1.75

43.76

1.4

1.3

21.36

62.49

u/ml

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

556

2948

1.90

43.38

1.3

98.30

50.10

u/ml

—

Nerve, nerve root and plexus disorders

948

3443

1.66

43.08

1.3

133.80

30.56

u/ml

—

Asthma, including avohilmo

1033

3499

1.63

43.08

1.2

1.3

62.07

41.52

u/ml

0.21

Other specific joint derangements/joint disorders

614

2071

1.86

41.28

1.2

1.4

15.30

51.55

u/ml

—

Medical observation and evaluation for suspected diseases and conditions

544

1426

1.96

40.86

1.3

40.05

41.56

u/ml

—

Other diseases of urinary system

868

2920

1.68

40.28

1.3

16.77

58.86

u/ml

—

Pulmonary eosinophilia, not elsewhere classified

12.82

39.94

1.2

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

850

3268

1.65

38.27

1.3

15.26

60.74

u/ml

—

Rheumatoid arthritis, including avohilmo

362

1741

2.10

37.82

1.2

—

20.38

u/ml

—

Acute sinusitis

456

2169

1.92

36.80

1.4

1.2

5.18

38.15

u/ml

—

Intestinal infectious diseases, including avohilmo, including avohilmo

980

3471

1.58

35.87

1.3

51.50

45.49

u/ml

0.05

Operations 2 for CAVS

327

1505

2.12

34.55

1.3

1.2

17.64

14.12

u/ml

—

Calcific aortic valvular stenosis, diagnosis (helper)

327

1505

2.12

34.55

1.3

1.2

17.64

14.12

u/ml

—

Calcific aortic valvular stenosis

327

1508

2.11

34.38

1.3

1.2

17.64

14.12

u/ml

—

Calcific aortic valvular stenosis, operated

327

1508

2.11

34.38

1.3

1.2

17.64

14.12

u/ml

—

Calcific aortic valvular stenosis, including rheumatic fever

328

1513

2.11

34.35

1.3

1.2

17.64

14.12

u/ml

—

Fall on same level

944

3256

1.55

31.85

1.2

1.3

17.40

54.53

u/ml

—

Dermatitis and eczema

942

3650

1.53

30.89

1.4

1.3

73.66

37.92

u/ml

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

845

3489

1.56

30.32

1.3

47.29

45.49

u/ml

0.01

Other intervertebral disc disorders

700

2574

1.63

29.68

1.3

74.27

53.41

u/ml

—

Pericarditis

103

5.61

29.26

1.4

1.0

—

u/ml

—

Gastroduodenal ulcer

264

1242

2.14

29.14

1.1

1.2

—

19.82

u/ml

—

Adrenocortical insufficiency

133

4.90

28.24

1.3

1.1

—

Other viral diseases

255

1199

2.14

28.13

1.5

1.3

99.70

18.19

u/ml

—

Other viral diseases, including avohilmo

315

1592

1.97

27.97

1.5

1.3

74.36

21.10

u/ml

—

Seropositive rheumatoid arthritis, wide

250

1180

2.14

27.65

1.1

1.2

—

28.72

u/ml

—

Symptoms and signs involving the digestive system and abdomen

827

2688

1.55

27.36

1.3

20.03

33.40

u/ml

—

Exposure to unspecified factor

842

3790

1.52

27.02

1.3

13.87

53.88

u/ml

—

Spondylopathies

657

2417

1.61

26.93

1.3

8.66

55.71

u/ml

—

Temporal arteritis

139

4.70

26.81

1.2

1.0

—

Other disorders of adrenal gland

168

4.29

26.72

1.3

1.2

—

Other functional intestinal disorders

403

2045

1.80

26.66

1.1

1.4

—

56.69

u/ml

—

Glucagon-like peptide-1 (GLP-1) analogues

278

1386

2.02

26.54

1.1

1.3

—

14.10

u/ml

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

278

1386

2.02

26.54

1.1

1.3

—

14.10

u/ml

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

240

1136

2.13

26.39

1.1

1.2

—

32.46

u/ml

—

Benign neoplasm of colon, rectum, anus and anal canal

573

2979

1.64

26.37

1.4

1.2

72.07

31.78

u/ml

—

Cerebrovascular diseases

651

2844

1.60

26.21

1.2

1.3

77.57

36.24

u/ml

—

Noninfective enteritis and colitis

394

2209

1.79

26.06

1.2

1.3

14.67

16.29

u/ml

—

Benign neoplasm: Colon

500

2808

1.68

26.05

1.4

1.2

28.16

54.75

u/ml

—

Other/unspecified seropositive rheumatoid arthritis

244

1172

2.10

25.83

1.1

1.2

—

28.72

u/ml

—

Recurrent and persistent haematuria

10.20

25.67

1.1

—

Acute upper respiratory infections

843

3402

1.49

24.38

1.6

1.2

6.64

56.50

u/ml

—

Diverticular disease of intestine

603

2358

1.60

24.12

1.3

19.68

57.95

u/ml

—

Giant cell arteritis with polymyalgia rheumatica

152

4.29

23.98

1.2

1.0

—

Drug-induced osteoporosis with pathological fracture

6.80

23.72

1.1

1.0

—

Gastric ulcer

177

777

2.30

23.52

1.2

1.1

—

20.60

u/ml

—

Symptoms and signs involving the skin and subcutaneous tissue

596

3610

1.57

23.40

1.3

61.10

46.90

u/ml

—

Persons encountering health services in other circumstances, wide

921

3255

1.46

23.28

1.3

12.50

60.77

u/ml

—

Disorders of gallbladder, biliary tract and pancreas

800

3356

1.49

23.23

1.2

1.3

75.24

39.90

u/ml

—

Use of hypnotics and sedatives

850

3315

1.47

22.85

1.5

1.2

17.05

56.06

u/ml

0.77

Sleep disorders (combined)

880

3156

1.46

22.51

1.2

1.4

18.50

53.57

u/ml

—

Drug-induced adrenocortical insufficiency

5.75

20.76

1.3

1.1

—

Injuries to the head

882

3670

1.43

20.72

1.2

1.3

9.86

50.75

u/ml

—

Lung diseases due to external agents

149

661

2.28

19.44

1.2

1.1

—

20.70

u/ml

—

Infection due to other mycobacteria

6.74

19.36

1.1

1.0

—

Short Achilles tendon (acquired)

4.97

19.30

1.3

—

Chronic apical periodontitis

868

3449

1.42

19.12

1.2

1.3

79.30

43.71

u/ml

—

Papulosquamous disorders

331

1940

1.72

19.04

1.2

—

21.52

u/ml

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

864

3248

1.42

18.99

1.2

1.3

17.38

60.77

u/ml

—

Pain (limb, back, neck, head abdominally)

553

1799

1.55

18.47

1.2

1.4

—

37.16

u/ml

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

20.61

17.67

1.6

1.0

—

Other neurological diseases

591

3113

1.48

17.39

1.1

1.3

11.68

51.18

u/ml

—

Infection due to other mycobacteria, including avohilmo

5.97

17.25

1.1

1.2

—

Iridocyclitis

196

1016

1.95

16.97

1.4

1.1

—

30.12

u/ml

—

Other viral diseases, not elsewhere classified, including avohilmo

207

1092

1.90

16.64

1.5

1.3

6.54

17.72

u/ml

—

Thrombotic microangiopathy

17.06

16.64

5.7

1.1

—

Kela reimbursement Agammaglobulinemia (D80-84)

7.54

16.32

1.3

1.1

—

Other dorsopathies, not elsewhere classified

739

2738

1.41

15.57

1.2

1.4

16.77

47.44

u/ml

—

Dorsalgia

723

2728

1.41

15.45

1.2

1.4

8.52

47.44

u/ml

—

Congenital malformations, deformations and chromosomal abnormalities

417

2592

1.53

15.08

1.3

99.46

32.55

u/ml

—

Personality disorders, excluding more controls

176

923

1.91

14.65

1.1

1.4

—

13.47

u/ml

—

Psoriasis

234

1347

1.75

14.53

1.1

1.2

—

27.27

—

Arthrosis

493

1814

1.49

14.50

1.2

1.3

—

60.51

u/ml

—

Periodontitis

762

3564

1.37

14.14

1.3

85.33

42.44

u/ml

—

Lumbar disc prolapse

484

2440

1.47

14.11

1.4

1.3

88.92

54.69

u/ml

—

Henoch-Schönlein purpura nephritis (HSPN)

18.70

13.96

1.2

2.0

—

Chronic periodontitis, including avohilmo

760

3565

1.36

13.95

1.3

85.33

42.44

u/ml

—

Rapidly progressive nephritic syndrome

26.23

12.62

1.8

1.1

—

Causalgia

5.38

12.58

1.1

—

Dorsopathies

734

2748

1.36

12.52

1.2

1.4

16.77

47.44

u/ml

—

Atypical mycobacterium lung infection

5.58

12.43

1.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

450

2841

1.45

12.40

1.3

99.46

30.21

u/ml

—

Allergic bronchopulmonary aspergillosis (ABPA)

20.13

12.38

1.4

1.0

—

u/ml

—

Other abnormal immunological findings in serum

4.47

12.24

1.2

1.1

—

Transport accidents

340

1859

1.53

12.10

1.2

1.4

—

34.90

u/ml

—

Dermatopolymyositis (FG)

5.84

12.04

1.0

1.1

—

Failure and rejection of transplanted organs and tissues

5.01

12.02

1.3

1.1

—

Other disorders of ear

686

3299

1.35

11.78

1.3

132.66

40.46

u/ml

—

Mycoses, including avohilmo

684

3891

1.34

11.72

1.3

65.48

42.07

u/ml

—

Hypersensitivity pneumonitis due to organic dust

4.43

11.60

1.2

1.1

—

Combinations of oral blood glucose lowering drugs

226

1375

1.65

11.55

1.1

1.3

—

14.91

u/ml

—

Other obstructive and reflux uropathy

104

3.61

11.47

1.1

1.2

—

Respiratory conditions due to other external agents

4.03

11.38

1.7

1.0

—

Tularaemia

5.31

11.36

1.1

—

Dependence on enabling machines and devices, not elsewhere classified

5.91

11.03

1.5

1.1

—

Lupus nephritis

19.72

11.00

1.0

1.1

—

Cardiodefibrillation

303

1997

1.52

10.88

1.2

—

19.45

u/ml

—

Drug-induced osteoporosis

4.98

10.58

1.0

1.1

—

u/ml

—

Tularaemia, including avohilmo

4.09

10.57

1.1

1.2

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

663

3912

1.32

10.41

1.4

1.3

11.51

60.30

u/ml

1.32

Caries of dentine, including avohilmo

582

2190

1.36

10.36

1.2

1.4

20.66

59.02

u/ml

—

Psoriatic and enteropathic arthropathies

400

2.17

10.23

1.1

—

Biological medicines for asthma

3.91

10.01

1.2

1.1

—

Asthma mixed form (mode), excluding more controls

3.68

9.97

1.1

—

Fibromyalgia

285

2.37

9.86

1.3

—

u/ml

—

Migraine without aura

119

632

1.89

9.79

1.1

1.3

—

17.42

—

Hernia

673

3420

1.31

9.72

1.4

1.3

82.67

45.92

u/ml

—

Zoster [herpes zoster], including avohilmo

388

2661

1.41

9.55

1.3

8.50

66.29

u/ml

—

Hypotension

152

878

1.74

9.54

1.1

—

20.70

u/ml

—

Polyarteritis nodosa

8.57

9.54

1.5

1.1

—

Sequelae of cerebrovascular disease

293

1683

1.49

9.53

1.3

11.43

17.76

u/ml

—

Spondylopathies (FG)

472

2.03

9.52

1.2

1.1

—

Dermatopolymyositis

4.63

9.38

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

748

3004

1.29

9.24

1.3

13.07

34.64

u/ml

—

Acquired absence of limb

5.21

9.19

1.2

1.1

—

Other conditions related to polyarteritis nodosa

27.28

9.17

1.8

1.2

—

Left bundle-branch block

216

2.52

9.11

1.1

1.0

—

Personality disorders

176

1071

1.65

9.10

1.1

1.3

—

24.04

u/ml

—

Diseases of the ear and mastoid process

804

3169

1.27

8.94

1.3

33.67

41.12

u/ml

—

Congenital iodine-deficiency syndrome/hypothyroidism

103

3.27

8.81

1.0

1.1

—

Poisoning by drugs, medicaments and biological substances

159

955

1.67

8.67

1.1

1.3

—

15.51

u/ml

—

Mental and behavioural disorders due to opioids

131

2.95

8.57

1.0

1.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

164

989

1.65

8.40

1.2

1.3

—

15.17

u/ml

—

Poisoning by medicine

142

840

1.70

8.23

1.1

1.3

—

21.06

u/ml

—

Asthma mixed form (mode)

3.22

8.21

1.1

—

Gingivitis and periodontal diseases

707

2868

1.28

8.06

1.3

13.36

44.56

u/ml

—

Conductive and sensorineural hearing loss

579

2960

1.30

8.06

1.3

110.78

44.38

u/ml

—

Systemic sclerosis (FG)

3.70

8.05

2.0

1.0

—

Disorders of adult personality and behaviour

181

1145

1.59

8.05

1.1

1.3

—

21.16

—

Superficial injury of head

179

1129

1.59

8.03

1.3

—

22.36

u/ml

—

Scleritis

4.39

8.00

2.6

1.1

—

Injuries to the shoulder and upper arm

623

3752

1.28

7.99

1.2

1.3

14.20

59.10

u/ml

—

Specific personality disorders

150

909

1.66

7.95

1.1

1.3

—

20.94

—

Juvenile arthritis (FINNGEN)

121

2.93

7.87

1.1

1.3

—

Viral and other specified intestinal infections

132

763

1.70

7.62

1.2

1.5

—

16.91

—

Other hammer toe(s) (acquired)

116

601

1.77

7.62

1.1

1.3

—

87.17

—

Secondary thrombocytopenia

4.22

7.61

1.2

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

223

1509

1.48

7.33

1.1

1.3

—

19.84

u/ml

—

Alkalosis

22.09

7.30

1.2

1.0

—

Other nonautoimmune haemolytic anaemias

15.92

7.15

1.0

1.1

—

Systemic sclerosis

3.40

7.14

2.0

1.0

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

10.17

6.97

1.2

1.0

—

Calcinosis cutis

18.91

6.96

1.5

1.2

—

Membranous nephropathy

8.45

6.78

1.1

—

Phobic anxiety disorders

440

1.87

6.65

1.1

1.6

—

22.08

—

ILD medications: pirfenidone

4.29

6.62

1.0

—

u/ml

—

Systemic sclerosis, icd10

3.22

6.60

2.0

1.1

—

312

2061

1.37

6.44

1.5

1.2

13.38

41.69

u/ml

—

Acute drug-induced interstitial lung disorder

6.22

6.40

2.3

1.0

—

Behavioural disorders, excluding more controls

3.77

6.36

1.1

1.3

—

Erythema nodosum

2.93

6.34

1.1

1.0

—

Use of anticholinesterases

132

1602

0.63

6.34

1.1

1.2

—

39.21

—

N06DA Anticholinesterases

132

1602

0.63

6.34

1.1

1.2

—

39.21

—

Nasal polyp

145

927

1.57

6.30

1.6

1.2

—

34.86

—

Molar incisor enamel hypoplasia, with caries

7.21

6.25

1.8

2.0

—

Other localized connective tissue disorders

3.35

6.18

1.3

1.2

—

Primary adrenocortical insufficiency

4.22

6.14

1.3

1.1

—

Myositis

2.88

6.13

1.3

—

Haemolytic-uraemic syndrome

12.31

5.96

1.1

1.0

—

Gonarthrosis,primary

634

3094

1.24

5.90

1.2

1.3

13.24

65.45

u/ml

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

3.89

5.87

1.5

1.3

—

Explicit fungal Sepsis

6.36

5.77

1.3

1.0

—

Explicit fungal Sepsis, including avohilmo

6.36

5.77

1.3

1.0

—

Type of accident

201

1403

1.44

5.74

1.1

1.3

—

21.72

u/ml

—

Fracture of lumbar spine and pelvis

165

1109

1.49

5.66

1.3

1.2

—

25.54

u/ml

—

Other meningitis

3.60

5.63

1.3

1.1

—

Hypoplasia of dental enamel

6.01

5.56

1.7

1.9

—

Other juvenile arthritis

116

2.61

5.56

1.1

1.3

—

Convalescence

178

2.27

5.49

1.2

—

Other abnormal findings of blood chemistry

185

2.24

5.46

1.0

1.1

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

9.85

5.41

1.0

1.1

—

Anosmia

5.18

5.33

1.3

1.1

—

Pleural plaque

448

1.76

5.23

1.2

1.1

—

13.12

u/ml

—

Skin changes due to chronic exposure to nonionizing radiation

290

1976

1.33

5.20

1.5

1.2

13.38

41.69

u/ml

—

Mixed connective tissue disease

3.40

5.19

1.1

—

Bipolar affective disorders

110

692

1.60

5.19

1.1

1.4

—

20.92

u/ml

—

Other extrapyramidal and movement disorders in other diseases

174

1209

1.45

5.15

1.1

1.2

—

28.72

u/ml

—

Pyoderma gangrenosum

5.38

5.14

1.1

—

Artificial opening status

210

2.12

5.12

1.1

—

u/ml

—

Other nonthrombocytopenic purpura

4.60

5.12

1.0

1.1

—

Other general symptoms and signs

126

2.45

5.10

1.1

—

Exclusion endpoint for clefts

3.12

5.08

1.1

1.4

—

Conduct disorder

3.07

4.97

1.1

1.4

—

Other hearing loss

204

1422

1.39

4.94

1.1

1.2

—

19.05

u/ml

—

Other specified congenital malformation syndromes affecting multiple systems

3.27

4.92

1.1

1.4

—

Actinic keratosis

280

1928

1.33

4.87

1.5

1.2

13.38

41.69

u/ml

—

Hypoparathyroidism

137

2.37

4.85

1.1

1.0

—

Disorders of the thyroid gland

630

3383

1.21

4.84

1.2

1.3

14.44

43.53

u/ml

—

Dementia in Alzheimer disease

814

0.54

4.81

1.1

—

11.32

u/ml

—

Behavioural disorders

3.11

4.81

1.1

1.3

—

Injuries to the wrist and hand

691

3830

1.20

4.80

1.3

8.52

52.36

u/ml

—

Crystal arthropathies, rheuma endpoint

2.93

4.79

1.0

—

Unspecified contracted kidney

5.71

4.67

1.1

1.0

—

Clear cell adenocarcinoma of kidney

198

2.09

4.67

1.5

1.1

—

u/ml

—

Folate deficiency anaemia

3.58

4.66

1.0

—

Viral meningitis

115

2.46

4.64

1.0

1.1

—

Schizophrenia or delusion, excluding more controls

175

1228

1.41

4.60

1.1

1.4

—

23.92

u/ml

—

Viral meningitis, including avohilmo

116

2.44

4.56

1.0

1.1

—

Deviated nasal septum

228

1696

1.35

4.52

1.2

—

19.39

u/ml

—

Migraine with aura

127

853

1.49

4.51

1.1

1.3

—

22.44

—

Chronic laryngitis and laryngotracheitis

608

1.59

4.48

1.1

1.2

—

32.46

u/ml

—

Primary Sclerosing Cholangitis, IBD and UDCA required

2.81

4.47

1.3

1.1

—

Progressive systemic sclerosis

7.85

4.41

3.9

1.2

—

Implicit parasitic Sepsis

7.81

4.40

1.0

1.1

—

Myocardial infarction, with ST-elevation

130

883

1.48

4.40

1.1

—

17.93

u/ml

—

conjunctival haemorrhage

345

1.78

4.38

1.5

1.1

—

Xerosis cutis

2.93

4.36

1.8

1.2

—

Malignant neoplasm of renal pelvis, including Hilmo

4.05

4.34

2.3

1.3

—

Redundant prepuce, phimosis and paraphimosis

155

1078

1.42

4.26

1.1

1.3

—

38.57

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

123

516

1.50

4.25

1.1

1.4

—

3.75

—

Other mycoses, not elsewhere classified/unspecified

6.23

4.21

1.3

1.1

—

Umbilical hernia

192

1411

1.37

4.19

1.2

—

8.63

u/ml

—

Migraine without aura and triptan purchases

545

1.58

4.03

1.1

1.4

—

15.17

—

Implicit parasitic Sepsis, including avohilmo

6.64

4.02

1.0

1.1

—

Other postsurgical states

232

1.91

3.96

1.1

—

Haemophagocytic lymphohistiocytosis

9.90

3.90

1.1

1.0

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

4.90

3.90

1.0

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

100

2.42

3.88

1.4

1.2

—

Cryoglobulinemia

13.11

3.85

1.0

1.2

—

Juvenile rheumatoid arthirtis

2.76

3.77

1.1

1.2

—

Polymyositis

4.26

3.74

1.1

—

Listeriosis, including avohilmo

5.22

3.74

1.0

—

u/ml

—

Blindness, monocular

3.69

3.74

1.1

—

Cardiomyopathy in other diseases

5.19

3.73

1.1

1.0

—

Unspecific neurodegenerative disorder

192

1746

0.75

3.73

1.1

1.2

—

33.43

u/ml

—

Intracranial and intraspinal abscess and granuloma

3.07

3.72

1.1

—

u/ml

—

Other spirochaetal diseases

117

1672

0.70

3.72

1.0

1.2

—

33.88

—

Lyme disease

116

1659

0.70

3.70

1.0

1.2

—

33.88

—

Lyme disease, including avohilmo

116

1659

0.70

3.70

1.0

1.2

—

33.88

—

Spirochaetal infections, other/unspecified, including avohilmo

117

1667

0.70

3.66

1.0

1.2

—

33.88

—

Use of donepezil

1030

0.63

3.66

1.1

—

10.80

—

therapeutic use

136

2.16

3.63

1.1

—

Nonalcoholic steatohepatitis

3.82

3.63

1.1

—

Dermatopolymyositis, unspecified

4.96

3.61

1.0

1.1

—

Necrotizing fasciitis

4.95

3.60

1.3

1.1

—

u/ml

—

Malnutrition

2.48

3.57

1.2

—

u/ml

—

Alzheimer disease, including avohilmo

165

1538

0.74

3.56

1.1

1.2

—

39.21

u/ml

—

Other spirochaetal diseases, including avohilmo

120

1692

0.71

3.55

1.0

1.2

—

33.88

—

Postzoster neuralgia

2.85

3.54

1.7

1.1

—

Vitamin D deficiency

2.74

3.51

1.1

1.2

—

Primary coxarthrosis, bilateral

195

1483

1.32

3.47

1.2

—

22.84

u/ml

—

Fibroblastic disorders

151

1107

1.37

3.43

1.1

1.3

—

24.23

u/ml

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

3.87

3.43

1.1

1.0

—

Corticotropin deficiency

4.18

3.42

1.2

1.1

—

Drug-induced myopathy

7.40

3.42

1.1

1.0

—

Diseases of middle ear and mastoid

344

2286

1.23

3.40

1.5

1.3

5.76

24.30

u/ml

—

Absence of one kidney, including avohilmo

6.04

3.40

1.3

1.1

—

Adult-onset Still disease

7.26

3.40

1.0

1.1

—

Livedoid vasculitis

5.97

3.39

1.0

1.1

—

Other/unspecified mastoiditis and related conditions

5.91

3.37

1.1

—

Dronedarone medication

2.34

3.35

1.1

1.0

—

Benign paroxysmal vertigo

186

1414

1.32

3.33

1.3

1.2

—

20.70

u/ml

—

Alzheimer’s disease, strict definition

1150

0.69

3.29

1.1

—

11.18

u/ml

—

Other autoimmune haemolytic anaemias

2.84

3.28

1.0

1.1

—

Malignant neoplasm of renal pelvis

4.88

3.27

3.1

1.0

—

Gangrene, not elsewhere classified

3.90

3.22

1.1

—

Listeriosis

4.67

3.15

1.0

—

u/ml

—

Hypertension, Pulmonary Arterial

4.59

3.13

1.1

1.0

—

Complications peculiar to reattachment and amputation

4.12

3.12

1.1

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

175

1333

1.32

3.12

1.1

1.3

—

19.96

u/ml

—

Cytomegaloviral pneumonitis

6.38

3.11

1.4

1.1

—

Lichenoid drug reaction

7.90

3.10

1.0

1.1

—

Moderate visual impairment, binocular

125

2.10

3.09

1.1

—

Secondary systemic amyloidosis

7.84

3.09

1.0

—

Cardiovascular devices associated with adverse incidents

11.22

3.06

1.4

1.0

—

Osteomyelitis of vertebra

6.11

3.06

1.3

1.1

—

Personal history of certain other diseases

2.92

3.03

1.2

1.0

—

Drug-induced systemic lupus erythematosus

4.41

3.02

1.1

—

Alzheimer disease

144

1375

0.75

3.01

1.1

1.2

—

9.74

u/ml

—

Relapsing polychondritis

10.49

3.01

1.4

1.2

—

Cutaneous lupus erythematosus

2.37

3.00

1.3

1.0

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

2.67

2.98

1.1

—

Disorders of refraction and accommodation

166

1260

1.32

2.96

1.1

1.3

—

23.96

u/ml

—

Other and unspecified bullous disorders

3.31

2.95

1.1

—

Hyperkinetic disorders, excluding more controls

332

1.61

2.92

1.1

1.6

—

14.25

—

Mitochondrial myopathy

5.58

2.90

1.0

1.2

—

Iron deficiency

2.39

2.90

1.0

1.2

—

Single spontaneous delivery

133

947

0.74

2.88

1.1

1.4

—

94.62

—

Other and unspecified aplastic anaemias

3.22

2.87

1.0

1.1

—

Family history of certain disabilities and chronic diseases leading to disablement

136

2.00

2.85

1.1

—

Abnormal reflex

4.59

2.82

1.1

—

Hand

4.58

2.82

1.3

1.1

—

Hyperaldosteronism

103

2.16

2.82

1.0

1.1

—

Complications following infusion, transfusion and therapeutic injection

2.50

2.81

1.2

1.1

—

Peptic ulcer

3.64

2.80

1.0

1.1

—

Absence of one kidney

5.30

2.78

1.3

1.1

—

Cerebral arteritis

8.68

2.78

1.0

—

Other disorders of patella

596

1.45

2.77

1.1

1.2

—

21.20

—

Use of memantine

118

1285

0.74

2.76

1.1

1.2

—

9.74

u/ml

—

Use of other anti-dementia drugs

118

1285

0.74

2.76

1.1

1.2

—

9.74

u/ml

—

Bursitis of shoulder

2.22

2.75

1.1

—

Drug-induced polyneuropathy

3.52

2.71

1.0

1.1

—

Respiratory tuberculosis, clinically confirmed

3.05

2.71

1.2

1.1

—

u/ml

—

Other injuries of lower limb, level unspecified

3.51

2.71

1.1

—

Unspecified protein-energy malnutrition

3.86

2.70

1.2

1.1

—

Other congenital malformations, not elsewhere classified

3.22

2.67

1.0

1.6

—

Artrosis, including avohilmo

524

2475

1.16

2.64

1.2

1.3

—

36.30

u/ml

—

Other/unspecified crystal arthropathies

3.70

2.60

1.0

1.1

—

Miliary tuberculosis

7.62

2.59

1.0

—

Congenital malformations of anterior segment of eye

4.08

2.58

1.0

1.1

—

Panniculitis, unspecified

3.11

2.58

1.0

1.1

—

Actinomycosis

5.63

2.57

1.0

—

Atrioventricular septal defect

5.63

2.57

1.0

2.2

—

Actinomycosis, including avohilmo

5.61

2.56

1.0

—

LSIL lesion of the vagina

2.76

2.56

1.2

1.1

—

Malignant neoplasm of endocrine gland

269

1.64

2.53

1.2

—

Anuria and oliguria

3.54

2.50

1.2

1.0

—

Disorders of adrenal gland, other and/or unspecified

4.49

2.49

1.3

1.1

—

ILD medications: nintedanib

3.93

2.49

1.1

1.0

—

Renal agenesis and other reduction defects of kidney, including avohilmo

3.92

2.49

1.3

1.0

—

Other and unspecified vaccines and biological substances

3.90

2.48

1.3

1.1

—

Inflammatory disease of uterus

430

1.49

2.45

1.4

1.2

—

u/ml

—

Alzheimer’s disease (Late onset)

1070

0.73

2.45

1.1

1.2

—

11.18

u/ml

—

Delivery

138

949

0.76

2.44

1.1

1.4

—

94.62

—

Mantle cell lymphoma

2.96

2.43

1.0

1.3

—

Disorder of pancreatic internal secretion, other and/or unspecified

3.41

2.41

1.1

1.0

—

Drug-induced interstitial lung disorders, unspecified

6.62

2.41

1.0

1.1

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

3.75

2.39

1.1

1.0

—

Medicines for HER+ breast cancer

118

1448

0.76

2.38

1.1

1.3

—

102.79

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.88

2.36

1.1

—

Hyperosmolality and hypernatraemia

2.86

2.35

1.0

1.3

—

u/ml

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

2.06

2.32

1.1

—

Intussusception

2.20

2.32

1.1

—

Tarsal tunnel syndrome

3.27

2.32

1.0

1.1

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

4.85

2.31

1.0

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

4.81

2.30

1.0

—

Pedestrian injured in other and unspecified transport accidents

2.79

2.28

1.2

1.1

—

u/ml

—

Cauda equina syndrome

2.59

2.28

1.2

1.1

—

Drug-induced tremor

3.18

2.25

1.1

1.0

—

Carcinoma in situ of skin of lip

5.76

2.23

1.2

1.1

—

Degenerative diseases of the nervous system

172

1544

0.80

2.22

1.1

1.2

—

16.92

u/ml

—

Mature T/NK-cell lymphomas, hilmo

2.44

2.21

1.3

1.1

—

Other and unspecified injuries of forearm

3.39

2.19

2.6

1.0

—

Systemic sclerosis,strict definition

3.39

2.19

1.0

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

633

1.35

2.18

1.1

1.5

—

13.44

—

Other disorders of carbohydrate metabolism

4.40

2.17

1.2

1.0

—

Tick-borne viral encephalitis

4.39

2.17

1.0

—

Other and unspecified mononeuropathies of lower limb

2.04

2.17

1.2

1.1

—

Personal history of medical treatment

2.82

2.15

1.3

1.1

—

Examination and encounter for administrative purposes

354

1.50

2.14

1.1

—

Disorders of conjunctiva

511

3484

1.14

2.12

1.2

1.3

17.48

61.58

u/ml

—

Disorders in reading

2.47

2.11

1.1

1.4

—

Disorders of synovium and tendon in diseases classified elsewhere

2.15

2.09

1.5

1.1

—

Other specified and unspecified disorders of iris and ciliary body

5.12

2.08

1.2

1.1

—

Unspecified threat to breathing

2.95

2.08

1.0

1.5

—

Unspecified mental disorder

223

1846

1.21

2.08

1.1

1.3

—

29.54

u/ml

—

Acquired pure red cell aplasia [erythroblastopenia]

3.61

2.08

1.1

—

Golimumab

117

1.89

2.06

1.1

1.2

—

Other degenerative diseases of the nervous system

162

942

1.26

2.06

1.1

1.3

—

57.03

u/ml

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

103

1.95

2.05

1.0

1.2

—

Disorders of pituitary gland, other and/or unspecified

4.08

2.05

1.2

1.1

—

Infections with a predominantly sexual mode of transmission

146

1155

1.26

2.04

1.1

1.3

—

13.48

—

Thiamine deficiency

3.15

2.03

1.1

1.0

—

Dissection of cerebral arteries, nonruptured

3.13

2.03

1.0

1.1

—

Acquired absence of organs, not elsewhere classified

2.54

2.02

1.1

1.3

—

Melanocytic naevi of upper limb, including shoulder

2.02

2.01

1.1

1.2

—

Operations for atrial fibrillation

2.18

2.00

1.0

1.1

—

Renal agenesis and other reduction defects of kidney

3.42

1.98

1.3

1.0

—

Chronic inflammatory disorders of orbit

4.71

1.96

1.6

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

100

1265

0.76

1.96

1.2

—

19.83

—

Other primary thrombocytopenia

4.66

1.95

1.4

1.1

—

Benign neoplasm of other and unspecified intrathoracic organs

2.60

1.95

1.1

—

Congenital varicose veins

4.64

1.95

1.0

1.1

—

Disorders of other and unspecified cranial nerves

3.83

1.95

1.0

1.1

—

Disease of hard tissues of teeth, NOS

330

1480

1.17

1.93

1.3

—

52.06

u/ml

—

Ovarian cyst

164

753

1.25

1.92

1.1

1.3

—

100.48

—

Schizophrenia, schizotypal and delusional disorders

176

1437

1.23

1.92

1.1

1.3

—

39.41

u/ml

—

Dissociative [conversion] disorders

114

1.85

1.87

1.2

—

Other and unspecified nonscarring hair loss

2.90

1.87

1.7

1.1

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

2.11

1.87

1.3

1.1

—

Schizophrenia or delusion

175

1433

1.22

1.87

1.1

1.3

—

39.41

u/ml

—

Acute myeloid leukaemia, including Hilmo

2.42

1.86

1.5

1.0

—

Acute myeloid leukaemia

2.42

1.86

1.5

1.0

—

Acute myeloid leukaemia, helper endpoint

2.42

1.86

1.5

1.0

—

Birth asphyxia

3.60

1.85

1.0

1.9

—

Nosocomial condition (hospital)

3.60

1.85

1.3

1.0

—

Other and unspecified disorders of adult personality and behaviour

3.60

1.85

1.0

1.1

—

Malignant neoplasm of thyroid gland

253

1.55

1.84

1.3

1.1

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

4.28

1.84

1.0

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

4.25

1.83

1.0

1.1

—

L02BG Aromatase inhibitors

1264

0.77

1.83

1.1

1.3

—

112.71

—

Acute inflammation of orbit

3.10

1.81

1.1

—

Exophthalmic conditions

2.61

1.81

1.1

—

2.60

1.81

1.0

1.1

—

Other congenital malformations of ear

2.60

1.81

1.0

1.5

—

Anxious personality disorder

2.19

1.78

1.3

—

Other specified/unspecified soft tissue disorders

169

1.67

1.77

1.1

—

Tick-borne viral encephalitis, including avohilmo

3.40

1.76

1.0

1.1

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

2.54

1.75

1.2

1.1

—

Other disorders affecting eyelid function

2.54

1.75

1.2

1.1

—

Malignant neoplasm of heart, mediastinum and pleura

2.25

1.75

1.0

1.2

—

Toxic liver disease

2.25

1.75

1.2

1.1

—

Other nonscarring hair loss

2.53

1.75

1.7

1.1

—

Malignant neoplasm of thyroid gland, including Hilmo

281

1.50

1.74

1.3

1.2

—

Palmar fascial fibromatosis [Dupuytren]

740

1.30

1.74

1.1

—

19.32

—

Dacryoadenitis

2.96

1.73

1.1

—

Myotonic disorders

2.96

1.73

1.4

1.1

—

2.70

1.73

1.0

1.1

—

Attention to artificial openings

155

1.69

1.73

1.2

1.1

—

Necrobiosis lipoidica, not elsewhere classified

3.91

1.72

1.0

1.1

—

Social disorders starting during childhood or adolecense, excluding more controls

3.89

1.72

1.0

1.8

—

Lack of expected normal physiological development

2.70

1.72

2.3

1.5

—

Congenital malformations of breast

2.31

1.71

1.0

1.4

—

Hyperhidrosis

2.01

1.69

1.1

—

Fracture of skull and facial bones

125

1000

1.25

1.69

1.2

—

18.04

u/ml

—

Malignant neoplasm of ureter, including Hilmo

2.62

1.67

3.4

1.4

—

Traction detachment of retina

2.62

1.67

1.0

1.1

—

Malignant neoplasm of other and unspecified parts of biliary tract

2.12

1.66

1.0

1.2

—

Tooth eruption problems

476

1.36

1.66

1.2

1.5

—

26.08

—

Hypoplasia of dental enamel , including avohilmo

100

1.84

1.66

1.6

1.3

—

Bus occupant injured in other and unspecified transport accidents

2.85

1.66

1.1

1.0

—

Pigmented purpuric dermatosis

2.47

1.65

1.0

1.1

—

Benign neoplasm: Rectum, anus and anal canal

128

1030

1.25

1.65

1.4

1.2

108.56

26.77

u/ml

—

Chromosomal abnormalities, not elsewhere classified

2.11

1.65

1.5

1.3

—

Pollen allergy

675

1.30

1.64

1.8

1.4

—

21.90

—

Congenital malformations of breast, including avohilmo

2.26

1.64

1.0

1.3

—

Agoraphobia

105

1.82

1.63

1.1

1.2

—

3.67

1.63

1.2

1.0

—

Marfan's syndrome

3.63

1.62

1.0

1.1

—

Protein-energy malnutrition of moderate and mild degree

2.53

1.60

1.1

—

u/ml

—

Dementia, including avohilmo

242

1924

0.86

1.60

1.1

1.2

—

33.43

u/ml

—

Rheumatic valve diseases

1.96

1.60

1.1

1.0

—

Occlusion and stenosis of arteries, not leading to stroke

2.35

1.59

1.0

—

Amblyopia ex anopsia

159

1.64

1.59

1.0

1.2

—

u/ml

—

Acquired clawhand, clubhand, clawfoot and clubfoot

3.06

1.59

1.0

1.1

—

Any dementia

199

1627

0.84

1.57

1.1

1.2

—

37.33

u/ml

—

Use of rivastigmine

786

0.73

1.57

1.1

—

12.20

—

Macular pucker

101

796

1.27

1.57

1.2

—

20.09

u/ml

—

Intentional self-harm by sharp object

1.98

1.54

1.0

1.3

—

Other adrenocortical overactivity

3.38

1.53

1.2

1.9

—

Birth trauma

3.38

1.53

1.0

1.1

—

Disorders of plasma-protein metabolism, not elsewhere classified

3.38

1.53

1.2

1.0

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

2.90

1.51

1.0

1.1

—

Migraine, unspecified, drug-induced

2.90

1.51

1.2

1.1

—

Autoimmune hepatitis

2.89

1.51

1.0

—

Vascular dementia

410

1.37

1.50

1.1

—

13.24

u/ml

—

Coxarthrosis, primary, with hip surgery

300

2438

1.14

1.48

1.1

1.3

—

37.80

u/ml

—

Essential (haemorrhagic) thrombocythaemia

147

1.64

1.48

1.0

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

232

1999

1.16

1.47

1.2

—

21.34

—

Other and unspecified disorders of autonomic nervous system

3.19

1.45

1.0

1.1

—

Malignant neoplasm of adrenal gland

3.19

1.45

1.0

—

Neuroendocrine tumor and carcinoma of stomach

3.18

1.44

1.0

—

Postinfectious hypothyroidism

3.17

1.44

1.0

1.1

—

Other and unspecified disorders of binocular movement

2.77

1.44

2.2

1.0

—

Social disorders starting during childhood or adolescence

3.16

1.44

1.0

1.9

—

Drug-induced hypoglycaemia without coma

1.99

1.44

1.0

1.1

—

Follow-up care involving plastic surgery

110

1.74

1.43

1.1

—

Dementia

224

1776

0.86

1.42

1.1

1.3

—

34.89

u/ml

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

1.87

1.41

1.1

—

Kela-code for severe mental illness

197

1684

1.17

1.40

1.1

1.3

—

29.54

u/ml

—

Trichomoniasis, including avohilmo

2.44

1.40

1.0

1.1

—

Chronic myeloid leukaemia, including Hilmo

2.44

1.40

1.0

—

Benign neoplasm: Rectum/anal canal icd-9

2.44

1.40

1.3

1.0

—

Migraine with aura and triptan purchases

527

1.31

1.39

1.1

1.4

—

15.17

—

Congenital malformations of uterus and cervix

2.09

1.39

1.2

1.3

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.02

1.39

1.0

1.4

—

Liveborn infants according to place of birth

2.68

1.38

1.2

2.0

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

2.65

1.37

1.2

1.1

—

Drug-induced gout

3.00

1.37

1.0

—

Acquired keratosis [keratoderma] palmaris et plantaris

3.00

1.37

1.0

1.2

—

Chronic myeloid leukaemia

2.99

1.37

1.0

1.1

—

Other and unspecified disorders of orbit

2.99

1.36

1.2

1.1

—

Felty syndrome

2.99

1.36

1.2

1.1

—

Intentional self-harm by jumping from a high place

2.98

1.36

1.0

1.1

—

Lower leg

2.98

1.36

1.0

1.1

—

Conotruncal defects

2.16

1.34

1.2

1.6

—

Other disorders of breast and lactation associated with childbirth

0.00

1.34

0.0

1.1

—

Seronegative juvenile rheumatoid arthritis

2.05

1.33

1.2

1.3

—

Hypermobility syndrome

128

1.65

1.33

1.1

—

u/ml

—

Other and unspecified medical devices associated with adverse incidents

2.55

1.31

1.2

1.0

—

Purulent endophthalmitis

2.54

1.31

1.2

1.0

—

Malignant neoplasm of adrenal gland, including Hilmo

2.53

1.31

1.0

—

Acute myringitis

2.53

1.31

1.0

1.1

—

Other disorders of central nervous system

2.11

1.31

2.1

1.1

—

Benign intracranial hypertension

2.52

1.31

1.0

1.1

—

Family history of other conditions

2.11

1.30

1.0

1.3

—

Idiopathic urticaria

1.86

1.30

1.1

1.2

—

Hypersplenism

2.83

1.29

1.0

—

Other proliferative retinopathy

2.83

1.29

1.0

—

Ovarian dysfunction, other/unspecified

2.81

1.29

1.0

1.2

—

Defects in the complement system

2.81

1.29

1.0

1.2

—

Benign neoplasm: Other and unspecified parts of small intestine

1.95

1.28

1.0

1.1

—

Abscess of external ear

2.10

1.28

1.0

1.1

—

Dissocial personality disorder

2.02

1.28

1.0

1.1

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.06

1.27

1.2

1.3

—

2.06

1.27

1.2

1.6

—

Atopic conjunctivitis

154

1.57

1.26

1.1

—

All dysplastic lesions of the vagina

1.83

1.25

1.1

—

Rheumatoid lung disease

2.45

1.25

1.5

1.0

—

Delivery, wide proxy

122

782

0.83

1.25

1.1

1.3

—

12.24

—

Abscess of tendon sheath

2.43

1.25

1.2

1.1

—

Disorders of parathyroid gland, other and/or unspecified

2.43

1.25

1.3

1.1

—

Leukaemia of unspecified cell type

2.25

1.25

1.0

—

Benign neoplasm: Bladder

2.25

1.25

1.0

1.1

—

Other papulosquamous disorders

2.24

1.25

1.0

1.4

—

Magnesium deficiency

2.70

1.23

1.2

1.1

—

Cardiomyopathy, Hypertrophic obstructive

1.98

1.22

1.0

—

Unspecified transport accident

2.67

1.22

1.6

1.1

—

Sequelae of intentional self-harm, assault and events of undetermined intent

2.66

1.22

1.0

1.1

—

Disorders of brain, other and unspecified

2.19

1.22

1.3

1.1

—

Evidence of alcohol involvement determined by level of intoxication

2.18

1.22

1.4

1.1

—

Other nutritional anaemias

2.18

1.22

1.0

1.1

—

Viral encephalitis, not elsewhere classified/unspecified

1.81

1.21

1.1

—

Unspecified event, undetermined intent

1.73

1.21

1.1

1.2

—

Perichondritis of external ear

1.85

1.20

1.2

1.1

—

Conjunctivitis

428

3127

1.10

1.19

1.2

1.3

17.48

63.46

u/ml

—

Trichomoniasis

2.33

1.19

1.0

1.1

—

Ankle and foot

2.33

1.19

1.0

1.1

—

6-mercaptopurine

1.75

1.19

1.1

1.0

—

Localized scleroderma [morphea]

2.02

1.17

1.1

1.3

—

Assault by blunt object

2.02

1.17

1.0

1.1

—

Seminoma of testis, including Hilmo

2.07

1.16

1.0

1.3

—

Wilms' tumor, including Hilmo

2.53

1.15

1.0

—

Complex cardiac defects

2.53

1.15

1.0

1.1

—

Personal history of risk-factors, not elsewhere classified

2.07

1.15

1.0

1.1

—

Other benign neoplasm of uterus: Corpus uteri

2.52

1.15

1.0

1.1

—

Other congenital malformations of face and neck

1.69

1.14

1.1

1.2

—

Crystalline deposits in vitreous body

2.02

1.12

1.1

—

Colitis, primary sclerosing

1.98

1.12

1.6

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

135

934

0.85

1.11

1.1

1.4

—

14.94

u/ml

—

Combined immunodeficiencies

2.28

1.11

1.0

1.1

—

Carcinoma in situ of vagina

2.41

1.09

1.0

1.1

—

Multifocal fibrosclerosis

2.41

1.09

1.4

1.0

—

Other specific arthropathies, wide

1.83

1.09

1.0

1.1

—

Nystagmus and other irregular eye movements

1.88

1.08

1.8

1.1

—

Papillary adenocarcinoma of thyroid gland

194

1.45

1.07

1.3

1.1

—

Other fall from one level to another

125

1059

1.18

1.06

1.2

1.3

—

21.12

—

Family history of malignant neoplasm

357

1.32

1.05

1.1

1.2

—

Acute hepatitis B

2.31

1.04

1.0

1.1

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

2.30

1.04

1.2

1.0

—

Acute epiglottitis

1.97

1.04

1.2

1.1

—

Unspecified parasitic disease

2.08

1.03

1.3

1.1

—

Unspecified parasitic disease, including avohilmo

2.08

1.03

1.3

1.1

—

Benign neoplasm: Vagina

2.07

1.03

1.3

1.1

—

Vitiligo

1.93

1.02

1.0

1.1

—

Other factor of the environment

1.89

1.01

1.1

—

Hereditary ataxia

1.89

1.01

1.0

1.1

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.89

1.00

1.0

1.1

—

Seminoma of testis

2.02

1.00

1.0

1.3

—

Benign neoplasm: Nasopharynx

2.02

1.00

1.1

—

Excessive vomiting in pregnancy

222

1.40

1.00

1.0

1.3

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

1.62

1.00

1.2

1.1

—

Wet age-related macular degeneration

105

851

1.19

0.99

1.1

—

14.26

—

Complications predominantly related to the puerperium

851

0.81

0.98

1.0

1.2

—

13.20

—

Special screening examination for neoplasms

257

1.37

0.98

1.1

—

Malignant neoplasm of other and unspecified parts of mouth

2.20

0.98

1.0

—

Nail dystrophy

2.20

0.98

1.8

1.0

—

Cardiomyopathies, Secondary/extrinsic

2.20

0.98

1.0

—

Cutis laxa senilis

2.19

0.98

1.0

1.1

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

2.19

0.98

1.4

1.0

—

Failed attempted abortion

2.19

0.98

1.0

1.1

—

Drug-induced obesity

1.96

0.97

1.0

1.1

—

Non-small cell lung cancer, including Hilmo

735

1.20

0.97

1.0

1.2

—

13.33

—

Cushing syndrome

1.96

0.97

1.0

1.1

—

Panhypopituitarism

1.75

0.97

1.6

1.1

—

Donors of organs and tissues

1.81

0.97

1.0

1.1

—

Other bursitis of hip

1.75

0.97

1.1

—

Mixed disorders of conduct and emotions, excluding more controls

1.81

0.96

1.0

1.3

—

Long labour

645

0.80

0.96

1.6

1.3

—

60.03

—

Other congenital malformations of upper alimentary tract

0.00

0.95

0.0

1.1

—

Hyperkinetic disorders

440

1.26

0.95

1.1

1.6

—

20.88

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.78

0.95

1.1

—

Benign neoplasm: Prostate

1.92

0.95

1.1

1.0

—

Liposarcoma, including Hilmo

1.91

0.94

1.0

1.3

—

IBD (strict) with PSC

1.91

0.94

1.7

1.1

—

Other demyelinating diseases of the central nervous system

117

1.54

0.94

1.0

1.1

—

Complications of other internal prosthetic devices, implants and grafts

175

1.43

0.93

1.1

—

Habit and impulse disorders

1.83

0.92

1.0

1.1

—

Surgical ablation of atrial fibrillation

2.18

0.92

1.0

1.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

109

951

0.85

0.91

1.1

1.4

—

138.81

—

Contusion of toe(s) without damage to nail

1.64

0.91

1.1

1.0

—

Retinal haemorrhage

110

1.55

0.91

1.1

1.0

—

Malignant neoplasm of other connective and soft tissue

1.60

0.91

1.0

1.2

—

Malignant neoplasm of breast, HER-positive

109

951

0.85

0.90

1.1

1.4

—

138.81

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

2.09

0.90

1.0

1.1

—

Xanthelasma of eyelid

2.09

0.89

1.0

1.1

—

Disturbance of activity and attention

419

1.26

0.89

1.1

1.6

—

20.88

—

Congenital malformations of pulmonary and tricuspid valves

2.02

0.87

1.2

1.6

—

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

2.02

0.87

1.0

1.4

—

Exposure to excessive heat of man-made origin

2.02

0.87

1.0

—

Blepharospasm

2.02

0.87

1.0

1.1

—

Sequelae of tuberculosis, including avohilmo

1.73

0.86

1.2

1.0

—

u/ml

—

Alcohol induced polyneuropathy

1.84

0.86

1.1

—

Arthropathy in ulcerative colitis

1.83

0.86

1.3

1.1

—

Fibrosis of liver

1.96

0.85

1.0

1.1

—

Other deformity of hallux (acquired)

1.95

0.85

1.2

1.1

—

Other and unspecified injuries of neck

1.95

0.85

1.0

1.1

—

u/ml

—

Migraine with aura, drug-induced

1.95

0.84

1.3

1.1

—

Lifestyle-related condition

1.79

0.84

1.1

—

Malignant neoplasm of vulva, including Hilmo

1.79

0.84

1.3

1.1

—

Hereditary deficiency of other clotting factors

1.89

0.82

1.3

1.1

—

Benign neoplasm: Scapula and long bones of upper limb

1.89

0.82

1.0

1.1

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

1.58

0.81

1.0

1.2

—

Other acute skin changes due to ultraviolet radiation

130

1.47

0.81

1.0

1.1

—

u/ml

—

Fistulae involving female genital tract

1.74

0.80

1.2

1.1

—

Pemphigus

0.00

0.79

0.0

1.1

—

Malignant neoplasm of gallbladder, including Hilmo

0.00

0.79

0.0

1.0

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

1.83

0.79

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

187

1652

1.12

0.79

1.1

1.4

—

41.86

—

Symptoms and signs involving emotional state

106

1.52

0.79

1.0

1.2

—

Use of dimethyl fumarate

0.00

0.78

0.0

1.1

—

Dysplastic lesion of unknown severity of the cervix uteri

0.00

0.78

0.0

1.2

—

Gestational [pregnancy-induced] hypertension

783

1.17

0.78

1.1

1.2

—

15.64

—

Contact with sharp object, undetermined intent

1.56

0.78

1.1

1.2

—

Pityriasis rosea

0.00

0.78

0.0

1.1

—

Other obstetric trauma

126

0.55

0.77

1.3

1.1

—

Thyrotoxicosis with toxic single thyroid nodule

1.78

0.76

1.0

1.1

—

Flatulence and related conditions

1.78

0.76

1.2

1.1

—

Tonsillectomy and adenotomy

226

1734

0.91

0.76

1.3

1.4

—

45.44

—

All dysplastic lesions of the vulva

132

1.44

0.76

1.2

1.4

—

Universal erythroderma, KELA reimbursement

1.71

0.75

1.0

1.1

—

Acute hepatitis B, including avohilmo

2.11

0.75

1.0

1.1

—

Deficiency of other B group vitamins

1.61

0.75

1.0

—

Other congenital malformations of peripheral vascular system

1.68

0.75

1.2

1.1

—

Other and unspecified acne

1.68

0.74

1.0

1.3

—

Other operation for atrial fibrillation

2.03

0.73

1.0

1.1

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

2.02

0.73

4.6

1.4

—

Motor- or nonmotor-vehicle accident in traffic area

2.02

0.73

1.8

1.0

—

Toxic effect of other and unspecified substances

1.81

0.72

1.0

1.1

—

Any dementia, excluding more controls

186

1417

0.90

0.72

1.1

1.2

—

8.54

u/ml

—

Torticollis

1.68

0.72

1.2

—

Other and unspecified injuries of thorax

1.59

0.72

1.0

1.1

—

Muscle strain

117

1.46

0.72

1.2

—

Exposure to unspecified smoke, fire and flames

1.76

0.71

1.1

1.0

—

HSIL lesion of the vulva

1.59

0.71

1.4

1.1

—

Injury of blood vessels at wrist and hand level

1.94

0.71

1.2

1.1

—

Senility

1.93

0.70

1.0

—

Injury of nerves and spinal cord at neck level

101

1.49

0.70

1.0

1.2

—

Abnormal findings on diagnostic imaging of breast

1.72

0.70

1.0

—

Other and unspecified trigeminal disorders

1.72

0.70

1.1

—

Other specified/unspecified deforming dorsopathies

1.56

0.70

1.2

1.3

—

False labour

581

0.85

0.69

1.1

1.3

—

6.75

—

1.87

0.68

1.0

1.1

—

Mesothelioma

1.68

0.68

1.0

1.3

—

Androgenic alopecia

1.86

0.68

1.0

1.6

—

Assault by sharp object

1.60

0.68

1.7

1.1

—

Chronic hepatitis NAS

1.68

0.68

1.1

—

Burn and corrosion of ankle and foot

1.53

0.68

1.3

1.1

—

Dental pulpitis, including avohilmo

480

3270

0.94

0.68

1.2

1.3

8.18

54.50

u/ml

—

Accidental poisoning by and exposure to alcohol

1.53

0.68

1.1

1.3

—

Routine general health check-up of defined subpopulation

1.53

0.68

1.3

—

Colitis due to radiation

1.64

0.67

1.0

1.3

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

267

1.28

0.66

1.1

1.2

—

Degenerative myopia

1.80

0.66

1.0

1.1

—

Malignant neoplasm of vulva

1.80

0.66

1.2

1.0

—

Urethritis and urethral syndrome

1.55

0.65

1.2

1.1

—

Other disorders of binocular vision

1.60

0.65

1.0

1.3

—

Congenital malformations of genital organs

275

1.27

0.65

1.2

1.3

—

Torsion of ovary, ovarian pedicle and fallopian tube

1.62

0.65

1.3

1.7

—

Conjunctivitis (acute, non atopic), including avohilmo

621

3552

1.06

0.65

1.4

1.3

3.97

66.31

u/ml

—

Unspecified dementia

453

0.81

0.64

1.1

—

9.93

—

1.74

0.64

1.0

1.1

—

Right ventricular outflow tract obstruction

1.74

0.64

1.2

1.7

—

Pseudomembranous colitis

1.74

0.64

1.2

1.1

—

Deep endometriosis

305

1.25

0.63

1.2

1.1

—

Congenital deformities of feet

1.50

0.63

1.0

1.2

—

Labour and delivery complicated by umbilical cord complications

131

0.61

0.63

1.1

—

Dermatitis herpetiformis

1.56

0.62

1.2

—

Torsion of testis

1.56

0.62

1.1

—

Infliximab

1.56

0.62

1.5

1.1

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.64

0.62

1.5

1.1

—

Sequelae of tuberculosis

1.60

0.62

1.2

1.0

—

u/ml

—

Burn and corrosion, body region unspecified

1.68

0.62

1.2

1.1

—

Cerebral palsy

1.61

0.61

1.0

1.3

—

Injury of blood vessels at hip and thigh level

0.00

0.61

0.0

1.1

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

0.60

0.0

1.1

—

Other and unspecified disease of Bartholin gland

1.48

0.60

1.2

1.0

—

Congenital dislocation of hip, unilateral

0.00

0.60

0.0

1.7

—

Colorectal neuroendocrine tumor and carcinoma

1.58

0.60

1.0

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.60

0.0

1.0

—

Malignant neoplasm of nasopharynx, including Hilmo

0.00

0.60

0.0

1.0

—

Paget disease

0.00

0.60

0.0

1.0

—

Degenerative conditions of globe

0.00

0.60

0.0

1.0

—

Other benign neoplasm of uterus: Other parts/unspecified

141

0.64

0.60

1.1

—

Other surgical follow-up care

122

1.40

0.60

1.1

1.3

—

Benign neoplasm: Scrotum

0.00

0.60

0.0

1.0

—

Traumatic ischaemia of muscle

1.55

0.59

1.1

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.55

0.59

1.4

1.3

—

Dyshidrosis [pompholyx]

1.54

0.59

1.0

—

Malignant neoplasm of rectosigmoid junction

1.57

0.59

1.0

1.2

—

Inflammation of lacrimal passages (acute and unspecified)

1.57

0.59

1.0

1.2

—

Dislocation of lens

1.52

0.58

1.0

1.2

—

Cerebral atherosclerosis

1.51

0.58

1.0

—

u/ml

—

Benign neoplasm of other and unspecified female genital organs

140

1.36

0.58

1.2

1.1

—

Other and unspecified injuries of ankle and foot

140

1.36

0.58

1.0

1.2

—

Neuroendocrine tumor and carcinoma of lung

1.73

0.58

1.2

1.0

—

Other and unspecified pemphigoid

1.73

0.58

1.2

1.0

—

Other abnormal auditory perceptions

1.72

0.58

1.0

1.1

—

Other and unspecified paralytic syndromes

1.49

0.57

1.0

1.1

—

Spontaneous abortion

156

1151

0.91

0.57

1.1

1.4

—

92.19

—

Abnormal spermatozoa

700

0.86

0.56

1.2

1.1

—

22.72

u/ml

—

Colitis, primary sclerosing, strict definition

1.63

0.55

1.5

1.1

—

Previous suicide attempt

1.63

0.55

1.0

1.1

—

Ventricular septal defect, a heart condition

1.51

0.55

1.0

1.4

—

Disorders of puberty

1.63

0.55

1.0

1.7

—

Isolated patent ductus arteriosus

1.61

0.55

1.2

1.6

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.59

0.54

1.7

1.6

—

Unspecified human immunodeficiency virus [HIV] disease

1.59

0.54

1.0

1.1

—

Hypertrophy of (infrapatellar) fat pad

1.59

0.54

1.0

1.1

—

Allergic contact dermatitis due to drugs in contact with skin

1.47

0.54

1.0

1.1

—

Thyrotropin deficiency

1.59

0.54

1.0

1.1

—

Prolapse and hernia of ovary and fallopian tube

124

0.64

0.54

1.1

1.0

—

Family history of other specific disorders

1.59

0.54

1.3

1.1

—

Inflammatory disorders of breast

186

1.29

0.54

1.1

—

Ankyloglossia

1.58

0.54

1.0

1.6

—

Juvenile osteochondrosis

1.42

0.54

1.1

1.2

—

Malignant neoplasm of testis

1.48

0.54

1.0

1.2

—

Carcinoma in situ of other and unspecified genital organs

1.46

0.53

1.2

1.1

—

Mixed disorders of conduct and emotions

1.46

0.53

1.0

1.4

—

Mixed specific developmental disorders

1.44

0.52

1.1

1.4

—

Injury of nerves at lower leg level

1.51

0.52

1.0

1.1

—

HSIL lesion of the vagina

1.51

0.51

1.0

1.1

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

1.47

0.50

1.3

—

Graves ophthalmopathy

1.43

0.49

1.1

—

Dermatophytosis, including avohilmo

382

3544

1.06

0.49

1.3

90.38

31.09

u/ml

—

Benign neoplasm: Oesophagus

1.53

0.48

1.4

1.1

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.42

0.47

1.1

—

Venous complications and haemorrhoids in pregnancy

1.46

0.47

1.0

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

105

948

1.11

0.46

1.7

1.2

—

26.92

u/ml

—

Localized skin eruption due to drugs and medicaments

1.44

0.46

1.1

—

Mesothelioma, including Hilmo

1.43

0.46

1.0

1.2

—

Other and unspecified injuries of abdomen, lower back and pelvis

1.43

0.46

1.0

1.1

—

Unspecified abortion

129

1.32

0.45

1.1

1.4

—

Sleep disorders

491

3537

0.95

0.45

1.2

1.3

37.40

56.48

u/ml

—

Benign neoplasm of thyroid gland

121

0.66

0.45

4.4

1.1

—

Other injuries of upper limb, level unspecified

1.41

0.45

1.0

1.3

—

Primary ovarian failure

1.40

0.45

1.0

1.1

—

Infections with a predominantly sexual mode of transmission, including avohilmo

174

1475

1.08

0.44

1.1

1.4

—

16.32

—

malignant neoplasm of female genital organs, including Hilmo

635

1.13

0.44

1.6

1.2

—

98.08

—

Synovial hypertrophy, not elsewhere classified

1.62

0.43

1.0

1.1

—

Other disorders of choroid

1.43

0.42

1.0

1.1

—

Tuberculosis of other organs, strict

0.64

0.42

1.2

1.1

—

Carcinoma in situ of vulva

1.57

0.42

1.4

1.1

—

Clubfoot

1.57

0.42

1.0

1.1

—

Obstructed labour due to malposition and malpresentation of fetus

650

0.88

0.42

1.7

1.3

—

60.03

—

Certolizumab pegol

1.41

0.42

1.0

1.1

—

Oxicams

139

725

1.09

0.42

1.2

1.4

—

28.68

—

Disorders of sexual preference

0.00

0.41

0.0

1.0

—

Monoplegia

1.38

0.41

1.0

1.1

—

Benign neoplasm: Other/unspecified site

1.38

0.41

1.1

—

Benign neoplasm: Epididymis

0.00

0.41

0.0

1.0

—

Other specified/unspecified disorders of ear

0.00

0.41

0.0

1.1

—

Other and unspecified water transport accidents

0.00

0.41

0.0

1.1

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

0.41

0.0

1.0

—

Congenital ptosis, including avohilmo

0.00

0.41

0.0

1.1

—

Acute mastoiditis

1.52

0.41

1.0

1.1

—

u/ml

—

Nonpyogenic thrombosis of intracranial venous system

1.52

0.41

1.0

1.1

—

Diastasis of muscle

1.52

0.41

1.0

1.1

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.41

0.0

1.9

—

Other congenital malformations of brain

0.00

0.41

0.0

1.9

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.00

0.41

0.0

1.9

—

Juvenile cataract

0.00

0.41

0.0

1.2

—

Prophylactic surgery

0.00

0.41

0.0

1.1

—

Chondrosarcoma, including Hilmo

0.00

0.41

0.0

1.0

—

Fatigue fracture of vertebra

0.00

0.41

0.0

1.5

—

Labour and delivery complicated by fetal stress [distress]

443

0.88

0.41

1.0

1.2

—

1.04

—

Acute otitis externa, noninfective

1.36

0.41

1.0

1.1

—

Shigellosis

0.00

0.41

0.0

1.1

—

Osteosarcoma, including Hilmo

0.00

0.41

0.0

1.0

—

Malignant neoplasm of gallbladder

0.00

0.41

0.0

1.1

—

Muscular dystrophy

1.48

0.40

1.2

1.1

—

Abnormality of white blood cells, not elsewhere classified

1.48

0.40

1.0

1.1

—

Calcific tendinitis

1.48

0.40

1.2

1.1

—

Foreign body in genitourinary tract

1.48

0.40

1.0

1.1

—

Tic and related disorders

1.47

0.40

1.0

1.4

—

Precocious central puberty

0.00

0.40

0.0

1.7

—

Impacted maxillary canine

1.43

0.39

1.0

1.7

—

Arthropathy in Crohn disease

1.43

0.39

1.0

1.1

—

Superficial injury of neck

1.41

0.39

1.1

1.2

—

Malignant neoplasm of gum

0.00

0.39

0.0

1.0

—

Benign neoplasm: Retina

0.00

0.39

0.0

1.1

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

106

0.66

0.39

1.0

1.1

—

Other congenital malformations of tongue, mouth and pharynx

1.42

0.39

1.0

1.7

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.38

0.38

1.2

1.7

—

Melanocytic naevi of eyelid, including canthus

1.39

0.38

1.2

1.1

—

Malignant neoplasm of bone and articular cartilage

1.39

0.38

1.0

—

Assault by other specified means

1.39

0.38

1.0

1.4

—

u/ml

—

Benign neoplasm: Vulva

1.35

0.38

1.1

—

Female genital prolapse

125

639

1.09

0.38

1.1

1.3

—

100.48

—

Malignant neoplasm of small intestine

1.35

0.38

1.0

1.3

—

Malignant neoplasm of testis, including Hilmo

1.33

0.37

1.0

1.2

—

Behavioural syndromes associated with physiological disturbances and physical factors

514

3612

0.96

0.37

1.2

1.3

37.40

56.48

u/ml

—

Respiratory distress of newborn

1.37

0.37

1.0

1.9

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.36

0.37

1.8

1.6

—

Myasthenia gravis

1.31

0.37

1.0

1.1

—

Diabetes insipidus

1.36

0.37

2.2

1.1

—

Burns classified according to extent of body surface involved

1.36

0.37

1.2

1.4

—

Tic disorders

1.35

0.37

1.0

1.7

—

Nontraumatic intracranial haemmorrhage

103

944

1.09

0.37

1.1

—

20.10

u/ml

—

Inflammatory disease of cervix uteri

207

1.21

0.36

1.0

1.1

—

u/ml

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

1.27

0.36

1.1

—

Foreign body in ear

1.27

0.36

1.1

1.2

—

Other drug-induced secondary parkinsonism

1.44

0.35

1.0

—

Frostbite

1.43

0.35

1.0

1.1

—

Hypothyroidism due to medicaments and other exogenous substances

1.43

0.35

1.2

1.0

—

u/ml

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.32

0.35

1.0

1.2

—

u/ml

—

Somnolence

1.40

0.35

1.0

1.1

—

Disorders of puberty, all

1.40

0.35

1.0

1.8

—

Maternal care for known or suspected abnormality of pelvic organs

538

0.90

0.35

1.1

1.3

—

6.75

u/ml

—

Procedures for purposes other than remedying health state

1.37

0.34

1.0

1.1

—

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

1.37

0.34

1.0

—

Gastrointestinal stromal tumor and sarcoma

1.37

0.34

1.0

1.3

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

1.36

0.34

1.0

1.5

—

Mental and behavioural disorders due to cannabinoids

100

1.30

0.33

1.2

1.1

—

Sleep disorders, other/unspecified

127

1.26

0.33

1.3

1.1

—

Malignant neoplasm of anus and anal canal, including Hilmo

1.31

0.33

1.2

1.0

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

1.31

0.33

1.2

1.1

—

Benign neoplasm: Lip

0.70

0.33

1.2

1.1

—

Patent foramen ovale

0.66

0.33

1.0

1.2

—

Neuroendocrine tumor and carcinoma of small intestine

1.28

0.32

1.0

1.3

—

1.33

0.32

1.2

1.1

—

Allergic conjunctivitis

281

2581

1.05

0.32

1.2

1.4

20.00

56.11

u/ml

—

CR(E)ST syndrome

1.35

0.31

1.0

1.1

—

Granuloma annulare

1.32

0.31

1.1

—

Graves ophthalmopathy, strict

1.34

0.30

1.1

—

Benign neoplasm of other and unspecified sites

120

1.25

0.30

1.2

1.1

—

Kyphosis

1.28

0.30

1.0

1.1

—

Burns and corrosions of multiple and unspecified body regions

1.29

0.30

1.2

1.3

—

Autoimmune thyroiditis

1.25

0.29

1.0

1.1

—

Other disorders of prostate

152

0.79

0.29

1.2

1.1

—

Congenital deformities of feet, including avohilmo

130

1.23

0.28

1.1

1.2

—

Hallux rigidus

545

1.10

0.28

1.1

1.2

—

26.92

—

Complications following abortion and ectopic and molar pregnancy

103

1.26

0.28

1.0

1.1

—

u/ml

—

Generalized epilepsy, strict definition

1.32

0.28

1.0

1.1

—

Malignant neoplasm of oropharynx

1.27

0.28

1.0

1.2

—

Other infestations, including avohilmo

1.23

0.27

1.1

1.0

—

Insomnia

480

3442

0.97

0.27

1.2

1.3

42.82

56.48

u/ml

—

Radiculopathy

701

1.08

0.27

1.1

1.2

—

20.52

—

Use of interferon beta-1a

0.70

0.26

1.0

1.1

—

Right bundle-branch block

123

1.22

0.25

1.1

1.0

—

Malignant neoplasm of tonsil and base of tongue

1.19

0.24

1.0

1.2

—

Granulomatous disorders of skin and subcutaneous tissue

1.25

0.24

1.1

—

Benign neoplasm: Skin of upper limb, including shoulder

1.29

0.24

4.3

1.1

—

Other bacterial agents as the cause of diseases classified to other chapters

1.32

0.23

1.2

1.1

—

Premenstrual syndrome

1.28

0.23

1.0

1.5

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.77

0.22

1.1

1.2

—

Palindromic rheumatism

1.25

0.22

1.0

1.1

—

Endometriosis of intestine

1.25

0.22

1.0

1.1

—

Malignant neoplasm of small intestine, including Hilmo

125

1.20

0.22

1.0

1.2

—

LSIL lesion of the vulva

1.27

0.22

1.0

1.1

—

Other benign neoplasms of uterus

189

0.85

0.22

1.1

—

Infections of breast associated with childbirth

0.74

0.22

1.0

1.1

—

Contact with venomous snakes and lizards

1.22

0.22

1.0

1.4

—

Carcinoma in situ of breast, other/unspecified

1.22

0.22

1.0

—

Habitual aborter

1.22

0.22

1.0

2.0

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

144

1.18

0.22

1.2

1.4

—

Merkel cell carcinoma of skin

0.00

0.21

0.0

1.0

—

Neurofibromatosis, type 2

0.00

0.21

0.0

1.1

—

Dengue fever [classical dengue], including avohilmo

0.00

0.21

0.0

1.1

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

0.21

0.0

1.1

—

Intermittent hydrarthrosis

0.00

0.21

0.0

1.1

—

Osteosarcoma

0.00

0.21

0.0

1.0

—

Osteogenesis imperfecta

0.00

0.21

0.0

2.3

—

Radiodermatitis

0.00

0.21

0.0

1.1

—

Malignant neoplasm of accessory sinuses

0.00

0.21

0.0

1.0

—

Melanoma in situ of scalp and neck

0.00

0.21

0.0

1.1

—

Small plaque parapsoriasis

0.00

0.21

0.0

1.0

—

Non-seminoma of testis

0.00

0.21

0.0

1.0

—

Other specified and unspecified disorders of conjunctiva

1.19

0.21

1.0

1.1

—

Benign neoplasm: Parathyroid gland

1.19

0.21

1.2

1.0

—

Other and unspecified cicatricial alopecia

0.00

0.21

0.0

2.3

—

Multiple congenital exostoses, including avohilmo

0.00

0.21

0.0

1.0

—

Malignant neoplasm of ureter

0.00

0.21

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue, unspecified

1.19

0.21

1.0

—

Other and unspecified heterotropia

0.00

0.21

0.0

1.1

—

Other and unspecified pemphigus

0.00

0.21

0.0

1.1

—

Rheumatic fever without mention of heart involvement

0.00

0.21

0.0

1.0

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.21

0.0

1.0

—

Convergence insufficiency and excess

1.19

0.21

1.0

1.1

—

Tic and related disorders

1.19

0.21

1.0

1.6

—

Balanced rearrangements and structural markers, not elsewhere classified

0.00

0.21

0.0

1.1

—

Disorders of puberty, other/unspecified

0.00

0.21

0.0

2.2

—

Enduring personality changes

0.00

0.21

0.0

1.0

—

Erythrasma

0.00

0.21

0.0

1.1

—

Liver disorders in diseases classified elsewhere

0.00

0.21

0.0

1.2

—

Exposure to controlled fire, not in building or structure

0.00

0.21

0.0

1.1

—

Crushing injury of ankle and foot

0.00

0.21

0.0

1.1

—

Yaws, including avohilmo

0.00

0.21

0.0

1.1

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.21

0.0

2.3

—

Feeding problems of newborn

0.00

0.21

0.0

1.3

—

Wide developmental disorders

102

0.78

0.21

1.3

—

Toxic encephalopathy

0.00

0.21

0.0

1.0

—

Chronic constrictive pericarditis

0.00

0.21

0.0

1.0

—

Hypertension, portal

0.00

0.21

0.0

1.2

—

Congenital ptosis

0.00

0.21

0.0

1.1

—

Discharge from other and unspecified firearms

0.00

0.21

0.0

1.0

—

Other disorders following mastoidectomy

0.00

0.21

0.0

1.0

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

0.21

0.0

1.2

—

Other fibroblastic disorders

0.00

0.21

0.0

1.1

—

Open wounds involving multiple body regions

0.00

0.21

0.0

1.1

—

Granulosa cell carcinoma of ovary

0.00

0.21

0.0

1.1

—

Other and unspecified neuropathies

0.00

0.21

0.0

1.1

—

Adrenomedullary hyperfunction

0.00

0.20

0.0

1.1

—

Malignant neoplasm of nasopharynx

0.00

0.20

0.0

1.1

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.20

0.0

1.1

—

Toxic effect of corrosive substances

0.00

0.20

0.0

1.1

—

Periodontal disease, other/unspecified

108

1.21

0.20

1.0

1.1

—

Use of glatiramer acetate

1.23

0.20

1.0

1.1

—

Intentional self-harm by unspecified means

1.20

0.19

1.0

1.4

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

1.16

0.19

1.0

1.1

—

Chronic Coagulation defects

1.24

0.19

1.4

1.1

—

Hypersomnia

1.13

0.18

1.2

1.1

—

Polycystic ovarian syndrome

137

1.17

0.18

1.1

1.2

—

u/ml

—

Helminthiases

1.21

0.18

1.0

1.1

—

Cyst of Bartholin Gland

100

1.20

0.18

1.0

1.1

—

Other and unspecified mental retardation

1.18

0.18

1.0

1.5

—

Benign neoplasm: Short bones of upper limb

1.17

0.18

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

736

1.06

0.17

1.1

1.3

—

17.52

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

1.15

0.17

1.3

1.2

—

Unspecified visual impairment (binocular)

1.13

0.17

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

262

2436

1.03

0.17

1.2

1.4

20.00

58.94

u/ml

—

Oral lichen planus and hypothyroidism or thyroxine medication

0.73

0.17

1.2

1.1

—

Schizotypal disorder

0.71

0.16

1.0

1.1

—

Carcinoma in situ of skin, other sites/unspecified

1.13

0.16

1.3

1.2

—

u/ml

—

Epiphora

1.20

0.16

1.4

1.1

—

Inflammatory disorders of male genital organs, not elsewhere classified

1.11

0.16

1.3

1.0

—

Tuberculosis of other organs

0.75

0.15

1.2

1.1

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

1.09

0.14

1.0

1.2

—

Alzheimer’s disease (Late onset), excluding more controls

472

0.95

0.13

1.1

1.3

—

11.06

u/ml

—

Other inflammation of vagina/vulva

0.81

0.13

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

228

1.10

0.13

1.2

1.3

—

u/ml

—

Other and unspecified corneal deformities and disorders

113

1.15

0.13

1.2

1.1

—

Alzheimer disease, excluding more controls

571

1.04

0.12

1.1

1.3

—

11.06

u/ml

—

Benign neoplasm: Spinal meninges

1.14

0.10

1.0

—

Benign neoplasm: Appendix

1.14

0.10

1.0

—

Vascular dementia (multiple infarctions)

1.14

0.10

1.2

1.0

—

Phakomatoses, not elsewhere classified

1.11

0.10

1.0

1.1

—

Injury of nerves at forearm level

1.11

0.10

1.0

1.1

—

Malignant neoplasm of tongue, including Hilmo

106

1.13

0.09

1.0

1.2

—

conjunctival degenerations and deposits

1.15

0.09

1.1

—

Hirsutism in women

1.06

0.09

1.0

1.4

—

Delayed milestone in childhood

1.04

0.09

1.6

1.7

—

Contracture of joint

1.04

0.09

1.0

1.1

—

Other conjunctival vascular disorders and cysts

1.14

0.09

1.0

1.1

—

Hypertrichosis

1.09

0.09

1.0

1.3

—

Malignant neoplasm of eye and adnexa, including Hilmo

1.07

0.08

1.0

1.2

—

Short stature, not elsewhere classified

1.07

0.08

1.0

1.6

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.03

0.08

1.2

1.1

—

Bruxism

1.03

0.08

1.3

1.1

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

0.82

0.08

1.2

1.0

—

Other bursal cyst

0.82

0.08

1.2

1.1

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

0.80

0.08

1.0

1.1

—

Brain meningioma

195

1.08

0.08

1.3

1.1

—

Vertigo of central origin

1.06

0.08

1.0

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs

1.03

0.08

1.0

1.2

—

Tinnitus

114

1113

1.02

0.07

1.2

—

32.26

—

Malignant neoplasm of ovary

176

1.08

0.07

2.7

1.1

—

Exposure to other and unspecified man-made environmental factors

1.05

0.07

1.0

1.1

—

Assault by unspecified means

1.05

0.07

1.0

1.1

—

Autism

0.86

0.07

1.3

1.2

—

Bulimia nervosa (incl. atypical)

0.85

0.07

1.0

1.3

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.82

0.07

1.0

1.1

—

Malignant neoplasm of oropharynx, including Hilmo

1.07

0.07

1.0

1.2

—

Mandibular retrognathia AND surgery (BSSO)

1.07

0.07

1.0

1.1

—

Gonococcal infection, including avohilmo

122

0.90

0.07

1.0

1.1

—

Alopecia areata

0.89

0.06

1.6

1.2

—

Benign neoplasm: Skin of lower limb, including hip

103

0.87

0.06

1.3

1.0

—

Erosion and ectropion of cervix uteri

104

0.86

0.06

1.2

—

Desensitization to allergens

172

0.93

0.06

1.1

1.2

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

1.11

0.05

1.0

1.2

—

Benign neoplasm: Liver

1.11

0.05

1.0

1.1

—

Pterygium

130

1.08

0.04

1.1

—

Benign neoplasm: Skin of eyelid, including canthus

711

0.98

0.02

1.2

1.3

—

32.46

u/ml

—

Bilateral sagittal split ramus osteotomy operation

107

0.93

0.02

1.0

1.1

—

Chronic conjunctivitis

104

1.06

0.01

1.1

1.2

—

u/ml

—

Benign neoplasm: Cranial nerves

116

0.95

0.00

1.3

1.1

—

Serous carcinoma of ovary, including Hilmo

124

1.05

0.00

3.5

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

156

0.96

0.00

1.1

—

Triptan medication for migraine, min. 3 purchases

242

1808

1.00

0.00

1.2

1.3

—

66.89

—

Disorders of acoustic nerve

104

0.96

0.00

1.3

1.0

—

Hyperfunction of pituitary gland

152

0.99

0.00

1.0

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP)

172

0.99

0.00

1.2

1.3

—

u/ml

—

Hyperprolactinaemia

1.01

0.00

1.0

1.1

—

Other eating disorders

147

1.02

0.00

1.0

1.2

—

Congenital ovarian cysts

122

0.98

0.00

1.1

1.5

—

Gonococcal infection

107

1.03

0.00

1.0

1.1

—

Intracerebral haemorrhage

586

1.01

0.00

1.2

1.1

—

20.70

u/ml

—

Exposure to other and unspecified animate mechanical forces

115

1.04

0.00

1.1

—

Maternal care for cervical incompetence

125

1.04

0.00

1.1

—

u/ml

—

Other endocrine disorders

167

0.97

0.00

1.1

1.3

—

u/ml

—

Beningn neoplasm: Meninges, unspecified

0.86

0.00

1.0

1.1

—

Other and unspecified disorders of lacrimal system

0.00

0.0

1.1

—

Malignant neoplasm of pyriform sinus

0.00

0.0

1.0

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

1.2

—

Benign neoplasm: Renal pelvis

0.00

0.0

1.1

—

Hyperkinetic disorders (excl. ADHD)

0.94

0.00

1.0

1.4

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.0

1.4

—

Noonan syndrome

0.00

0.0

1.1

—

Actinic reticuloid

0.00

0.0

1.1

—

Carcinoma in situ of liver, gallbladder and bile ducts

0.00

0.0

1.0

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.0

1.0

—

Femoral hernia, bilateral

0.00

0.0

1.0

—

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

0.00

0.0

1.2

—

Unicornuate uterus

0.00

0.0

1.3

—

Malignant neoplasm of tongue

0.93

0.00

1.0

1.2

—

Cytomegaloviral hepatitis

0.00

0.0

1.3

—

Carcinoma in situ of oesophagus

0.00

0.0

1.1

—

Toxic effect of pesticides

0.00

0.0

1.2

—

Retained (old) foreign body following penetrating wound of orbit

0.00

0.0

1.0

—

Maxillary retrognathism

0.97

0.00

1.2

1.5

—

Other accidental hanging and strangulation

0.00

0.0

1.0

—

Carcinoma in situ of breast

0.00

0.0

1.2

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.0

1.1

—

Congenital myopathies

0.00

0.0

1.1

—

Bradycardia, unspecified, drug-induced

0.00

0.0

1.1

—

Pityriasis alba

0.00

0.0

1.0

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

3.0

—

Urethral discharge

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Amputation of ankle

0.00

-0.00

0.0

1.2

—

Rheumatic heart disease, other

0.00

-0.00

0.0

1.2

—

Maxillary hypoplasia

0.00

-0.00

0.0

1.0

—

Complications of anaesthesia during the puerperium

0.00

-0.00

0.0

1.3

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.2

—

Melanocytic naevi of scalp and neck

0.97

-0.00

1.1

1.2

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

Polyp of middle ear

0.00

-0.00

0.0

1.1

—

Nightmares

0.00

-0.00

0.0

1.0

—

Choroidal detachment

0.00

-0.00

0.0

1.0

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

-0.00

0.0

3.4

—

Haemolytic disease of fetus and newborn

0.00

-0.00

0.0

1.0

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

1.0

—

Neonatal aspiration syndromes

0.00

-0.00

0.0

1.0

—

Other perinatal haematological disorders

0.00

-0.00

0.0

2.5

—

Yaws

0.00

-0.00

0.0

1.0

—

Shoulder region

0.86

-0.00

1.2

1.1

—

Chronic respiratory disease originating in the perinatal period

0.00

-0.00

0.0

2.2

—

Pituitary-dependent Cushing's disease

0.00

-0.00

0.0

1.1

—

0.85

-0.00

1.2

1.1

—

Fetal death of unspecified cause

0.00

-0.00

0.0

1.3

—

Use of pergolide

0.00

-0.00

0.0

1.1

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of pyriform sinus, including Hilmo

0.00

-0.00

0.0

1.0

—

Abuse of non-dependence-producing substances

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of cervix uteri, including Hilmo

0.99

-0.00

1.0

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

1.1

—

Cicatricial pemphigoid

0.00

-0.00

0.0

1.1

—

Tuberous sclerosis 1

0.00

-0.00

0.0

1.1

—

Paranoid personality disorder

1.01

-0.00

1.0

1.1

—

Defect, injury or illness of face

0.00

-0.00

0.0

1.0

—

Sexual assault by bodily force

0.00

-0.00

0.0

1.3

—

Edwards' syndrome and Patau's syndrome

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.02

-0.00

1.0

—

Unspecified drowning and submersion

0.00

-0.00

0.0

1.2

—

Supernumerary ureter

0.00

-0.00

0.0

2.9

—

Hereditary lymphedema, including avohilmo

0.00

-0.00

0.0

1.2

—

Tympanosclerosis

0.00

-0.00

0.0

1.2

—

Thyrotoxicosis factitia

0.00

-0.00

0.0

1.2

—

Other mosquito-borne viral fevers

0.00

-0.00

0.0

1.1

—

Other haemoglobinopathies

0.00

-0.00

0.0

1.0

—

Other helminthiases, including avohilmo

0.00

-0.00

0.0

1.0

—

Other and unspecified firearm discharge, undetermined intent

0.00

-0.00

0.0

1.0

—

Erysipeloid

0.00

-0.00

0.0

1.2

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

-0.00

0.0

1.0

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

1.2

—

Chlamydial lymphogranuloma (venereum), including avohilmo

0.00

-0.00

0.0

1.0

—

Strongyloidiasis

0.00

-0.00

0.0

1.0

—

Occupant of streetcar injured in transport accident

0.00

-0.00

0.0

1.2

—

Exposure to high and low air pressure and changes in air pressure

0.00

-0.00

0.0

1.1

—

Follicular keratosis (Darier-White)

0.00

-0.00

0.0

1.2

—

Neuromyelitis optica

0.00

-0.00

0.0

1.3

—

Folliculitis decalvans

0.00

-0.00

0.0

1.1

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.0

—

Ophthalmic devices associated with adverse incidents

0.00

-0.00

0.0

1.2

—

Night blindness

0.00

-0.00

0.0

1.0

—

Strongyloidiasis, including avohilmo

0.00

-0.00

0.0

1.0

—

Sleep terrors [night terrors]

0.00

-0.00

0.0

1.0

—

Filariasis, including avohilmo

0.00

-0.00

0.0

1.2

—

Transient acantholytic dermatosis [Grover]

0.00

-0.00

0.0

1.0

—

Dengue fever [classical dengue]

0.00

-0.00

0.0

1.1

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

1.0

—

Drowning to ice

0.00

-0.00

0.0

1.1

—

Accident to watercraft causing drowning and submersion

0.00

-0.00

0.0

1.0

—

Acne varioliformis

0.00

-0.00

0.0

1.1

—

Chromomycosis and phaeomycotic abscess

0.00

-0.00

0.0

1.1

—

Leprosy [Hansen's disease]

0.00

-0.00

0.0

1.0

—

Assault by drugs, medicaments and biological substances

0.00

-0.00

0.0

1.1

—

Explosion and rupture of other specified pressurized devices

0.00

-0.00

0.0

1.0

—

Photocontact dermatitis [berloque dermatitis]

0.00

-0.00

0.0

1.0

—

Inflammation of lacrimal passages (chronic)

0.97

-0.00

1.0

—

Congenital lactase deficiency

0.00

-0.00

0.0

1.0

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

-0.00

0.0

1.1

—

Bacterial agents resistant to antibiotics

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Brain, supratentorial

0.98

-0.00

1.2

1.1

—

Hereditary lymphedema

0.00

-0.00

0.0

1.2

—

Mechanical strabismus

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Aortic body and other paraganglia

0.00

-0.00

0.0

1.2

—

Von Hippel-Lindau syndrome

0.00

-0.00

0.0

1.2

—

Melanoma in situ of ear and external auricular canal

0.00

-0.00

0.0

1.1

—

Rifle, shotgun and larger firearm discharge

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of tonsil, including Hilmo

0.88

-0.00

1.0

1.2

—

Single ventricle heart

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of other endocrine glands and related structures

0.00

-0.00

0.0

1.0

—

Leprosy [Hansen's disease], including avohilmo

0.00

-0.00

0.0

1.0

—

Type 1 diabetes, strict definition, subgroup 2

0.00

-0.00

0.0

1.0

—

Pemphigus vulgaris

0.00

-0.00

0.0

1.1

—

Adhesive middle ear disease

1.02

-0.00

1.0

—

Carcinoma in situ of bronchus and lung

0.00

-0.00

0.0

1.0

—

Crushing injury of forearm

0.00

-0.00

0.0

1.0

—

Filariasis

0.00

-0.00

0.0

1.2

—

Burn and corrosion of head and neck

0.96

-0.00

1.1

1.2

—

Fat embolism (traumatic)

0.00

-0.00

0.0

1.0

—

Central nervous system disorder causing precocious puberty

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of larynx

0.00

-0.00

0.0

1.0

—

Crushing injury of lower leg

0.00

-0.00

0.0

1.0

—

Ulcer of vagina/vulva

0.96

-0.00

1.0

1.2

—

Unspecified pneumoconiosis

0.00

-0.00

0.0

1.0

—

Other sudden death, cause unknown

0.00

-0.00

0.0

1.2

—

Drug-induced fever

0.00

-0.00

0.0

1.1

—

Traumatic subcutaneous emphysema

0.00

-0.00

0.0

1.0

—

Endocrine disorders, other/unspecified

0.88

-0.00

1.0

1.1

—

u/ml

—

Multiple congenital exostoses

0.00

-0.00

0.0

1.0

—

Subclinical iodine-deficiency hypothyroidism

0.00

-0.00

0.0

1.0

—

Autism spe

0.93

-0.00

1.3

1.4

—

Other helminthiases

0.00

-0.00

0.0

1.0

—

Lagophthalmos

0.89

-0.00

1.4

1.1

—

Malignant neoplasm of tonsil

1.00

-0.00

1.0

1.2

—

Kaschin-Beck disease

0.00

-0.00

0.0

1.2

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Pineal gland

0.00

-0.00

0.0

1.0

—

Congenital malformations of the nervous system

0.99

-0.00

1.3

—

Chondrosarcoma

0.00

-0.00

0.0

1.0

—

Asymmetry of jaw

1.02

-0.00

1.0

1.3

—

Huntington disease

0.00

-0.00

0.0

1.1

—

Retained (old) intraocular foreign body

0.00

-0.00

0.0

1.1

—

Abnormal pulmonary venous return

0.00

-0.00

0.0

1.0

—

Acanthosis nigricans

0.00

-0.00

0.0

1.1

—

Benign muscular dystrophy (Becker)

0.00

-0.00

0.0

1.1

—

Pyogenic granuloma

0.92

-0.00

1.0

1.1

—

Knuckle pads

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.95

-0.00

1.0

1.2

—

Ischaemic infarction of muscle

0.00

-0.00

0.0

1.0

—

Calculus of urinary tract in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Osteolysis

0.00

-0.00

0.0

1.1

—

Cyst of spleen

0.00

-0.00

0.0

1.0

—

Patellar tendinitis

0.94

-0.00

2.0

1.1

—

Benign neoplasm: Carotid body

0.00

-0.00

0.0

1.2

—

General autosomal fish scale disease

0.00

-0.00

0.0

1.2

—

Iliac crest spur

0.00

-0.00

0.0

1.0

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

1.2

—

Benign lipomatous neoplasm of spermatic cord

0.00

-0.00

0.0

1.0

—

Profound mental retardation

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

-0.00

0.0

1.1

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glomerular basement membrane Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS